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ABSTRACT
Neural Biosensor Probes for Simultaneous Electrophysiological Recordings,
Neurochemical Measurements, and Drug Delivery with High Spatial and Temporal
Resolution
by
Matthew Donivan Gibson
Chair: Daryl R. Kipke
The aim of this work is to develop and validate novel neural biosensor probes for simul-
taneous electrophysiological and neurochemical measurements with precise, localized
drug delivery. This technology has been developed to interface with the complex
environment of the brain for more advanced experimental investigations at the inter-
sections of neurophysiology, neuropathology, and neuropharmacology. The validation
experiments have been conducted using relevant in vivo testbeds as a foundation for
future work to more fully understand and treat neurological disorders.
Chapter II presents a multimodal probe that enables concurrent detection of
choline, recording of electrophysiology, and localized drug delivery. Central to this
work is the development of selective electrodeposition methods for enzyme immo-
bilization and polymerization on individual microelectrode sites that more closely
approach the scale of neurons than currently reported neural biosensors.
Multiple neurotransmitter systems are implicated in the pathophysiology of schizophre-
nia, Alzheimer’s disease, Parkinson’s disease, and other neurological disorders, yet the
direct relationships remain unclear. The ability to simultaneously monitor multiple
xii
chemical signals concurrently with electrophysiology and integrated pharmacological
manipulation can serve as a useful tool to further these investigations. Chapter III
further extends the probe capabilities to include glutamate sensing concurrent with
choline sensing, electrophysiology recordings, and drug delivery.
Electrochemical biosensors are commonly used to record neurotransmitter dy-
namics, yet there remains no standard calibration media or procedure. Differences in
calibration procedures can impact reported performance making the interpretation of
in vivo difficult. Chapter IV aims to improve our ability to interpret in vivo neuro-
chemical recordings by investigating the influence of calibration media on performance
characteristics of amperometric biosensors.
Bridging the electrophysiological and neurochemical domains with sufficient fi-
delity, resolution, sensitivity, and selectivity can provide novel insights into neuro-
physiology that lead to improved therapeutic approaches for treating neurological
disorders.
xiii
CHAPTER I
Introduction
The brain is one of the most complex and remarkable systems known to mankind.
It consists of an estimated 100 billion neurons, each with hundreds to thousands of
synaptic connections to other neurons (Damasio, 2001). The cortex alone has 20 bil-
lion neurons with 1.5×1014 synapses (Pakkenberg and Gundersen, 1997; Pakkenberg
et al., 2003). The brain interacts with other physiological systems through a myriad
of electrical pulses, neurotransmitters, hormones, proteins, and dynamic interconnec-
tions. With its central role in physiology, the brain has been the focus of scientific
research for many centuries. Yet due to its inherent complexity, our understanding of
neurophysiology and our ability to treat neurological disorders has remained limited.
In many ways, the brain remains the final frontier of human physiology. Debilitating
and costly disorders such as Alzheimer’s disease, Parkinson’s disease, schizophrenia,
depression, and multiple sclerosis remain prevalent throughout society.
The past century, and particularly the past several decades, have witnessed re-
markable developments in neural interfaces from novel neuroscience tools to promising
clinical treatments. One of the most significant challenges in neuroscience technol-
ogy is to bridge the electrophysiological and neurochemical domains with sufficient
fidelity, resolution, sensitivity, and selectivity to enable thorough investigation of the
complex interplay between chemical signals and electrical signals, and their resulting
1
influence on memory, perception, sensation, and behavior. Various methods provide
insight to individual components of these signals, yet few tools exist for simultane-
ously recording neurochemical and electrophysiological activity with high spatial and
temporal resolution. The ability to simultaneously integrate multiple neurophysio-
logical signals is an unmet need that can strengthen the current investigational and
therapeutic strategies for neuropathologies.
The work embodied in this dissertation aims to further expand upon this grow-
ing toolset through the development and validation of high density neural biosensor
arrays that enable simultaneous monitoring of choline, glutamate, and electrophys-
iology combined with localized drug delivery. Multi-modal neural biosensor probes
will enable more advanced experimental investigations at the intersections of neuro-
physiology, neuropathology, and neuropharmacology through the integration of these
fundamental neural signals.
1.1 Fundamentals of Neurophysiology
Neurons are the fundamental unit of the nervous system. The connections between
neurons form marvelous networks that provide the human body with all its function.
Since detailed discussion of neurons can be found in many textbooks, only a brief
overview for introducing the context of this work will be provided here (see also
Kandel et al., 2000; Squire, 2003; Purves, 2008).
Neurons consist of several important regions. The cell body, or soma, is the core
of the cell. Two types of branches extend from the soma for sending and receiving
signals to and from other neurons. Neurons have a single axon, which is the path-
way for signal conduction away from the soma to other neurons. The point at which
an axon connects to another cell is called a synapse. The axon may branch many
times and form multiple connections to other neurons. For example, in the cortex
of humans, each neuron has an average of 7000 synapses (Pakkenberg et al., 2003).
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Figure 1.1: Neuron Structure and Communication. Neurons consist of the soma
(cell body), axon (for transmitting signals to other neurons), dendrites (for receiving
signals), and synapses (the connections between neurons). Action potentials travel
through the axon to the synapses where neurotransmitters are released to excite or
inhibit the activity of other neurons. Figure courtesy of www.nia.nih.gov and used in
accordance with reproduction policies.
Neurons typically have receiving branches called dendrites, from which a neuron re-
ceives inputs from other neurons. Synaptic terminals can form at dendrites, somas,
and occasionally on other axons.
Neurons communicate through both electrical and chemical signals. The electrical
signals travel through the axon and dendrites. Neurons have an electric potential
across the cell membrane due to a concentration difference of various ions, including
K+, Na+, and Cl – . This concentration gradient is maintained through selective ion
channels and pumps. In the resting state, the membrane potential is typically around
-70mV (intracellular vs. extracellular). This potential can be calculated by using the
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Goldman equation (Goldman, 1943), which is a generalization and extension of the
Nernst equation (see also Hille, 2001; Bard and Faulkner, 2001; Kandel et al., 2000):
Em =
RT
zF
ln
[ion]out
[ion]in
Nernst equation (1.1)
Em =
RT
F
ln
∑Ni PC+i [C+i ]out +∑Mj PA−j [A−j ]in∑N
i PC+i [C
+
i ]in +
∑M
j PA−j [A
−
j ]out
 Goldman equation (1.2)
Where Em is the membrane potential, R is the gas constant, T is the temperature
in Kelvin, z is the ion valence, F is the Faraday constant, [ion]out and [ion]in are ion
concentrations outside and inside the neuron, P is membrane permeability (cm/s), C
represents cations, and A represents anions.
In the specific case of Na+, K+, and Cl – , the three primary ions in the cytoplasm
and extracellular cerebrospinal fluid, the Goldman equation goes to:
Em =
RT
F
ln
(
PNa+ [Na
+]out + PK+ [K
+]out + PCl− [Cl
−]in
PNa+ [Na+]in + PK+ [K+]in + PCl− [Cl−]out
)
(1.3)
In the pioneering work of Hodgkin and Katz (1949), it was determined that the
permeability ratios of these ions in the resting state were PK : PNa : PCl = 1.0 :
0.04 : 0.45, in the action potential peak PK : PNa : PCl = 1.0 : 20 : 0.45, and in the
refractory period PK : PNa : PCl = 1.8 : 0 : 0.45.
The resting potential of a neuron is primarily due to the difference in K+ con-
centrations, which has high permeability in the resting state (see Table 1.1 as well
as Hodgkin and Katz, 1949 and Hille, 2001). The permeability of other ions, and
Na+ particularly, changes dramatically as voltage-gated ion channels open and close
at the membrane to allow ionic flow to propagate the action potential. Small changes
in the K+ concentration can cause depolarization or hyperpolarization. This prop-
erty is particularly leveraged in the current work to drive transient neural activity
4
Ions Intracellular Extracellular Nernst E Resting Peak Potential Refractory
(mM) (mM) (mV) Permeability Permeability Permeability
K+ 150 5.5 -86 1.0 1.0 1.8
Na+ 15 150 +60 0.01-0.04 20 0
Cl – 10 125 -66 0.1-0.45 0.45 0.45
Ca+ 0.0001 2 +180
Table 1.1: Ionic Concentrations, Nernst Potential, and Permeability in Mammalian
Neurons
Adapted from Hille (2001), Pritchard and Alloway (1999), Hodgkin and Katz (1949),
and Wright (2004).
for validating the function of biosensor arrays. Since the concentrations of ions are
tightly modulated by physiological systems, a portion of the work in this dissertation
also focuses on understanding how the ionic concentrations affect the biosensor per-
formance to improve the correlation between measured responses and physiological
levels of various neurotransmitters.
Excitatory and inhibitory inputs summate at a point of the soma called the axon
hillock. When a depolarization threshold is crossed (approximately -55mV), a rapid
electrical pulse, or action potential, propagates through the axon to the synapses as
voltage-gated ion channels allow an influx of Na+. At the synaptic cleft, the action
potential causes the release of synaptic vesicles containing neurotransmitters. The
neurotransmitters transverse the synaptic cleft by diffusion and bind to postsynap-
tic receptors to enable communication between neurons across the network. These
receptors may be excitatory or inhibitory, and may directly modulate ion channels
(ionotropic) or activate other signaling cascades (metabotropic). Neurotransmitters
include dopamine, acetylcholine, glutamate, serotonin, and various neuropeptides.
1.2 Fundamentals of Electrochemistry
Electrochemistry utilizes electrodes and electrical properties of molecules to in-
vestigate experimental systems. While the broad set of electrochemical techniques
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utilize and measure virtually every electrical property of a system (potential, current,
impedance, capacitance, frequency response, analyte concentration, geometry, elec-
trode material, reaction kinetics, mass transfer, etc.), this discussion will focus on
two primary branches of electrochemistry that are particularly useful for developing
tools for investigating neurophysiology: potentiometry and voltammetry. In-depth
discussion on additional electrochemical techniques, theory, and instrumentation can
be found in the texts of Kissinger and Heineman (1996), Bard and Faulkner (2001),
and Zoski (2007). For a text specifically on electrochemical methods in neuroscience,
refer to Michael and Borland (2007).
Potentiometry is an electrochemical method which uses potential as the measured
variable during a zero current flow condition. The potential between two electrodes
(working electrode and reference electrode) is monitored.
Emeasured = Eworking − Ereference (1.4)
In electrochemical experiments, the working electrode is made selective for a par-
ticular molecule (such as H+ for a pH sensor) such that the measured potential reflects
the concentration of the analyte of interest.
Voltammetry differs from potentiometry in that potential of the working electrodes
is controlled by external instrumentation (potentiostat), and the current at the elec-
trode is measured (Figure 1.2). The resulting faradaic (oxidation or reduction) current
can be related to the analyte concentration. This current is also dependent on the
shape and magnitude of the voltage waveform. Three common forms of voltamme-
try are cyclic voltammetry (triangle wave), chronoamperometry (square wave), and
constant potential amperometry (O’Neill, 1994; Phillips and Wightman, 2003).
Cyclic voltammetry results in oxidation and reduction peaks that can provide a
6
Figure 1.2: Diagram of an Electrochemical Cell. A bias applied at the working elec-
trode versus the reference electrode can drive the oxidation or reduction of analytes.
The resulting current from electron release can be related to the concentration of the
analyte. In potentiometry no bias is applied, but rather the potential at the working
electrode is measured.
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chemical signature for identifying specific molecules with greater selectivity. Similarly,
chronoamperometry can offer a measure of selectivity through the ratio of oxidation
to reduction currents. Both cyclic voltammetry and chronoamperometry are limited
in temporal resolution by the period of the waveform, which is typically around 10Hz
with carbon fiber electrodes for in vivo voltammetry for neural recordings.
Applying a constant potential (“constant potential amperometry”) can further im-
prove temporal resolution, because the limiting factors are diffusion and the sampling
rate of the potentiostat, not the period of the waveform. Since constant potential
amperometry oxidizes or reduces all molecules at the surface that have a formal po-
tential of lesser magnitude than the applied potential, this technique has no inherent
selectivity. Permselective membranes can be used to increase selectivity by limiting
the molecules that can diffuse to the electrode surface.
1.2.1 Microelectrodes
Microelectrodes are of particular interest for studying neurophysiological dynam-
ics to enable spatial resolution on the order of neuron sizes (approximately 10µm
diameter). Microelectrodes with dimensions in the micron range (typically consid-
ered < 25µm) perform differently than their macro counterparts in regard to electro-
chemical processes (Bard and Faulkner, 2001; Kissinger and Heineman, 1996). First,
the redox reactions of the analyte at the electrode interface will not affect the bulk
concentration of the analyte, which can increase the accuracy of concentration mea-
surements. Second, the current at the electrodes are typically in the picoamp or
nanoamp range. As a result, the ohmic iR voltage drop across the electrolyte so-
lution is trivial and the applied potential more closely matches the true bias at the
electrode. In most cases, a two electrode system can be used as illustrated in Fig-
ure 1.2. Finally, at the microelectrode interface, radial or convergent diffusion (as
opposed to planar diffusion) is the dominant mode of mass transfer, which results in
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Figure 1.3: Planar Diffusion and Radial Diffusion. As the electrode dimensions are re-
duced, radial diffusion plays an increasingly large role at the electrode interface, thus
altering the way microelectrodes perform compared to their macroelectrode counter-
parts.
higher charge density and greater relative sensitivity (Figure 1.3).
While advantageous in many regards, these functional differences of microelec-
trodes mean that moving from the macroelectrode scale, where most electranalytial
sensors have been developed, to the microelectrode realm, is not a straight-line pro-
cess. For example, electrodeposited polymers exhibit different behaviors as the elec-
trode size goes smaller, which is likely due to the increased role of radial diffusion,
resulting in higher charge densities and edge effects (McMahon et al., 2004; Rothwell
et al., 2009). Rothwell et al. (2009) used electrodes of various geometries (disks and
cylinders) and sizes to investigate the relationship between electrode dimensions and
polymer deposition characteristics. They found that as electrodes are made smaller
and, more specifically, the ratio of the edge to the area (edge density) grows, the
permselectivity of phenylenediamine for H2O2 over ascorbic acid degraded (Figure
1.4). One significant challenge of the work presented in this dissertation involves the
development of selective functionalization strategies for microelectrodes.
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Figure 1.4: Relationship between Probe Geometry and the Performance of the Perms-
elective Membrane Phenylenediamine (Originally published in Rothwell et al. (2009).)
Plots of averaged values of ascorbic acid permeability (P(AA)%) for seven variations
of Pt electrode geometry and size versus working electrode area (left), edge length
(middle), and edge density (right). R2 values were calculated using linear regression.
For the bottom plot (edge density), the results were significant, indicating that as
edge density increases, the performance of phenylenediamine degrades. For planar
electrodes, edge density increases as size decreases.
1.3 Recording in vivo Neurophysiology
1.3.1 Recording Electrophysiology
Bioelectric potentials generated by neurons and other excitable cells, such as mus-
cle, can be measured through a form of potentiometry. If an electrode is placed in the
changing biopotential field, small currents will flow across the electrode-electrolyte
interface. In this case, instead of measuring a molecular concentration (e.g. pH), the
potential changes at the electrode reflect the local biopotentials (Webster and Clark,
1998).
Several established experimental methods, including patch-clamp techniques, mi-
crodialysis, and microelectrodes, have provided a wealth of information to neuro-
scientists and clinicians about the function of the brain. Choice of technique is
application-driven as each of these methods is primarily used to directly observe
either neurochemical or electrophysiological activity, but typically not both.
Foundational work by pioneers such as Hodgkin, Huxley, Katz, Neher, Sakmann,
and others paved the way for advanced in vivo investigations of the brain (Hodgkin
10
Michigan Probe Utah Array Microwire Array
Figure 1.5: Neural Probes. Three common neural probes include the Michigan Probe,
Utah Array (Rousche and Normann, 1998), and microwire array. Image of microwire
array is from the public domain and courtesy of Steve M. Potter.
and Huxley, 1939; Hodgkin and Katz, 1949; Neher and Sakmann, 1976; Kipke et al.,
2008). Numerous microelectrodes have been developed for monitoring in vivo extra-
cellular electrophysiology, including platinum microwires (Schwartz, 2004), the Utah
array (Maynard et al., 1997), and the Michigan probe (Wise et al., 2004), (Figure
1.5). Microwire electrodes, which typically consist of 1–4 insulated microwires with
exposed tips, are simple, but have proven to be quite effective in recording unit ac-
tivity and local field potentials in many experiments. The Utah array offers high
electrode density with 100 electrode sites for recording or stimulation.
Michigan probes, which are fabricated with photolithography and microfabrication
techniques, have a large range of design parameters for electrode size, shape, and
material (Wise et al., 2004). While originally based on silicon technology, recent
designs have used polymers, such as parylene, as a substrate (Pellinen et al., 2005;
Seymour and Kipke, 2007; Purcell et al., 2009; Seymour et al., 2011). These probes
were developed for recording electrophysiological signals in vivo for neural prosthetic
devices. They have also been used for electrical stimulation (Weiland and Anderson,
2000). Work from van Horne et al. (1992) showed some success in using the Michigan
probe technology for neurochemical sensing, but these early attempts were not fully
developed. More recently, the Michigan probe has been used in vivo to monitor the
activity single neurotransmitters such as dopamine (Johnson et al., 2008) and choline
(Gibson and Kipke, 2008).
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1.3.2 Recording Neurochemistry
Various methods are used to explore neurochemical dynamics of the brain. The
two most common methods today are microdialysis and voltammetry (Figure 1.6).
Microdialysis has become an indispensable tool for monitoring and modulating neu-
rochemical activity in the brain (Watson et al., 2006). Microdialysis probes typically
consist of a semi-permeable membrane, an inlet tube for perfusing fluids such as
extracellular fluid or pharmacological agents, and an outlet tube for sampling the
fluid within the probe, called the dialysate. The dialysate is analyzed by high pres-
sure liquid chromatography or capillary electrophoresis to determine the molecules
present. A notable advantage of microdialysis is its high selectivity and sensitivity.
Microdialysis methods allow for accurate identification of multiple chemical species
at nanomolar concentrations.
Microdialysis has traditionally suffered from low spatial and temporal resolution.
Typical microdialysis probes have a diameter of several hundred microns and sampling
rates of 10-20 minutes, which stands in contrast to synaptic events occurring on
a millisecond timescale. Recent work using capillary electrophoresis, laser-induced
fluorescence detection, and segmented dialysate flow in Robert Kennedy’s lab at the
University of Michigan have improved the temporal resolution to the order of seconds
for several neurotransmitters (Bowser and Kennedy, 2001; Kennedy et al., 2002; Shou
et al., 2004, 2006; Shackman et al., 2007; Wang et al., 2008).
In vivo voltammetry with carbon and platinum electrodes (Figure 1.6) is an estab-
lished method for sensing various neurotransmitters including dopamine (Wiedemann
et al., 1991; Wightman et al., 1988; Phillips and Wightman, 2004; Cheer et al., 2005),
acetylcholine or choline (Burmeister and Gerhardt, 2003; Mitchell, 2004; Parikh et al.,
2004; Bruno et al., 2006; Burmeister et al., 2008), and glutamate (Burmeister and
Gerhardt, 2001; Hascup et al., 2008) with sub-micromolar sensitivity and subsecond
temporal resolution (O’Neill, 1994). One advantage of voltammetry is its high tem-
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Platinum Electrode Array
Figure 1.6: Neurochemical Probes. Three common neurochemical probes include
microdialysis probes (Watson et al., 2006), carbon fiber electrodes (Robinson et al.,
2003), and ceramic substrate platinum electrode arrays (Burmeister et al., 2005).
poral resolution, which enables the differentiation of phasic signals from slower tonic
changes. Monitoring these faster dynamics has recently impacted our understanding
of various neurochemical systems, including dopamine, glutamate, and acetylcholine
(Parikh et al., 2007; Sarter et al., 2009; Parikh et al., 2008; Parikh and Sarter, 2008).
Histological analysis of neuronal density, gliosis, and microglia activation have indi-
cated that microelectrodes cause less tissue damage than microdialysis probes, which
has been hypothesized to increase signal integrity (Khan and Michael, 2003; Borland
et al., 2005; Hascup et al., 2009; Yang et al., 1998).
Carbon fibers are commonly used in conjuction with cyclic voltammetry and
chronoamperometry for the measurement of electroactive molecules, such as cate-
cholamines (e.g. dopamine) and serotonin. Other neurotransmitters, such as acetyl-
choline and glutamate, are not electroactive and cannot be measured directly with
voltammetric methods. The most common approach for electrochemically detecting
these molecules is to enzymatically convert them to an electroactive reporter molecule
(e.g. Hydrogen Peroxide or H2O2) with an appropriate oxidase enzyme immobilized
on the surface of the electrode (Burmeister and Gerhardt, 2001; Mitchell, 2004; Roth-
well et al., 2009). The H2O2 is then oxidized at the electrode with an applied electrical
potential (typically +700mV vs. Ag/AgCl). The following generalized reactions de-
scribe these processes (“Ox” represents an oxidase enzyme and “FAD” represents
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flavin adenine dinucleotide, which becomes FADH2 when oxidized) (Rothwell et al.,
2009):
Substrate + Ox/FAD→ Products + Ox/FADH2 (1.5)
Ox/FADH2 + O2 → Ox/FAD + H2O2 (1.6)
H2O2 → O2 + 2H+ + 2e− (1.7)
Platinum electrodes have high catalytic activity for the oxidation of H2O2 and thus
are frequently used for the amperometric detection of molecules through the above
mechanism (Burmeister et al., 2000; Burmeister and Gerhardt, 2003; Burmeister et al.,
2005; Mitchell, 2004; Rothwell et al., 2009).
The selectivity of the amperometric biosensors is improved through permselective
membranes to inhibit the molecules that can diffuse to the electrode surface, while
maintaining permeability to the molecule of interest (H2O2 in this case). Common
permselective membranes include Nafion (Gerhardt et al., 1984; Parikh et al., 2004)
and phenylenediamine (Mitchell, 2004; Rothwell et al., 2008; Parikh et al., 2008).
Additionally, multi-site biosesnor arrays can further increase specificity through “self-
referencing,” a technique in which a proximate reference electrode site is coated with-
out the enzyme (Burmeister and Gerhardt, 2001; Phillips and Wightman, 2003). The
signal from this reference site includes similar non-specific currents that can be sub-
tracted from the sensing site to reduce or eliminate interference signals from the
recordings. An example of this form of referencing is diagrammed in Figure 1.7
1.4 Previous Work from our Lab
As a foundation for this work, our lab has recently demonstrated the utility of
multi-electrode neural probes in recording neurochemical field dynamics with mi-
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Figure 1.7: Diagram of Neurochemical Referencing on a Single Array. The left site
represents a choline sensitive site and the right site represents a chemical reference
site without choline oxidase. Acetylcholinesterase converts acetylcholine to choline,
which then can diffuse to the electrode. On the sensing site, the choline is converted
to H2O2 and oxidized at the surface. A permselective membrane prevents potential
interferents (depicted by the triangle and square) from reaching the surface. In the
case that an interferent reaches the electrode surface (triangle), it will do so on both
sites, thus can be subtracted from the signal.
croelectrode arrays. Specifically, we have conducted experiments, led by Matthew
Johnson, in recording pH dynamics through potentiometric methods and dopamine
through constant potential amperometry (Johnson et al., 2007, 2008).
1.4.1 pH
Neural probes with 16 iridium microelectrode sites on a single shank were mod-
ified by electrochemically growing pH-sensitive hydrous iridium oxide on individual
electrode sites (Johnson et al., 2007). These probes, which showed selective linear
sensitivity to pH, were used to record local pH changes during probe insertion at
various speeds as a measure of local tissue trauma (Figure 1.8). The electrochem-
ical modification of individual electrode sites is a fundamental concept shared with
aspects of the current body of work.
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Figure 1.8: Spatiotemporal pH dynamics during probe insertion. Originally published
in Johnson et al. (2007). Spatiotemporal pH plots revealed more robust long-term
acidosis across the array for slower insertion speeds as well as variability in the re-
sponse along the probe shank. Shown are representative 2mm–deep insertions at (A)
0.05mm/s, (B) 0.50mm/s, and (C) 1.0 mm/s. Upper plots (AC) illustrate a detailed
picture of the pH response during the act of insertion (gray bars), while the lower
plots show a 10 min response window. A triphasic acidicalkalineacidic waveform,
which included substantial long-term acidosis, was evident following the slowest in-
sertions. Speeds of 0.50 and 1.00mm/s typically elicited a biphasic alkalineacidic
waveform with a muted acidosis trough. The average pH at each contact site 500s
after insertion had a significant spatial component for (D) the 0.05mm/s insertions
(R2= 0.67, n = 11 implants) and to a lesser extent for (E) the 0.50mm/s insertions
(R2= 0.32, n = 5 implants) and (F) the 1.00mm/s insertions (R2 = 0.19, n = 8 im-
plants). Consistent across these implants, however, was a general trend of superficial
contact sites recording more long-term acidosis than sites located near the tip. Error
bars correspond to standard errors.
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1.4.2 Dopamine
We recently demonstrated concurrent recordings of local field potentials, unit
activity, and dopamine eﬄux in the striatum of anesthetized rats using silicon neural
probes with interdigitated platinum and iridium sites spaced at 200µm (Johnson et al.,
2008). Dopamine was monitored amperometrically at either +350mV or +500mV
vs. Ag/AgCl at four platinum electrode sites, which were dip-coated with Nafion to
reduce possible signal interference from ascorbic acid and other interferents. Electrical
stimulation of the medial forebrain bundle (MFB) produced spatially heterogeneous,
but reproducible, dopamine eﬄux, and measurable changes in unit activity and local
field potentials (Figure 1.9).
The dopamine-electrophysiology work served as an initial foundation for multi-
modal sensors. The current work builds upon this fundamental multi-modal recording
work by extending sensing capabilities to nonelectroactive molecules (choline/acetylcholine
and glutamate), adding chemical reference sites for improved signal integrity, and
adding localized drug delivery capabilities.
1.5 Dissertation Organization
The aim of this work is to develop and validate novel neural biosensor probes
for simultaneous electrophysiological and neurochemical measurements with precise,
localized drug delivery. This technology has been developed to interface with the
complex environment of the brain for more advanced experimental investigations at
the intersections of neurophysiology, neuropathology, and neuropharmacology. The
validation experiments have been conducted using relevant in vivo testbeds as a
foundation for future work to more fully understand and treat neurological disorders.
Chapter II presents a multimodal probe that enables concurrent detection of
choline, recording of electrophysiology, and localized drug delivery. Central to this
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Figure 1.9: MFB stimulation elicited local field potential modulation and dopamine
release in striatum. Originally published in Johnson et al. (2008). MFB stimulation
elicited local field potential modulation and dopamine release in striatum. (A) The
figure shows an example recording session sampled continuously during electrochem-
ical recordings for dopamine on adjacent sites (indicated by numbers 1-4 next to the
probe). Following MFB stimulation (indicated by the gray bar), slow-wave activity
was suppressed considerably and coincided with the emergence of higher frequency
activity. (B and C) Event-averaged spectrograms showed significant modulation in
the 0–20 and 40–90 Hz bands following stimulation (n = 5 trials). Above each plot
is the event-averaged dopamine response recorded on an adjacent site. Recordings
reflect the presence of nomifensine (10mg/kg).
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work is the development of selective electrodeposition methods for enzyme immo-
bilization and polymerization on individual microelectrode sites that more closely
approach the scale of neurons than currently reported neural biosensors.
Multiple neurotransmitter systems are implicated in the pathophysiology of schizo-
phrenia, Alzheimer’s disease, Parkinson’s disease, and other neurological disorders,
yet the direct relationships remain unclear. The ability to simultaneously monitor
multiple chemical signals concurrently with electrophysiology and integrated phar-
macological manipulation can serve as a useful tool to further these investigations.
Chapter III further extends the probe capabilities to include glutamate sensing con-
current with choline sensing, electrophysiology recordings, and drug delivery.
Electrochemical biosensors are commonly used to record neurotransmitter dy-
namics, yet there remains no standard calibration media or procedure. Differences in
calibration procedures can impact reported performance making the interpretation of
in vivo difficult. Chapter IV aims to improve our ability to interpret in vivo neuro-
chemical recordings by investigating the influence of calibration media on performance
characteristics of amperometric biosensors.
Finally, Chapter V provides a conclusion for this work and suggestions for future
directions. Bridging the electrophysiological and neurochemical domains with suf-
ficient fidelity, resolution, sensitivity, and selectivity can provide novel insights into
neurophysiology that lead to improved therapeutic approaches for treating neurolog-
ical disorders.
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CHAPTER II
Neural Biosensor Arrays for Simultaneous
Recordings of Cholinergic Activity and
Electrophysiology with Integrated Drug Delivery
2.1 Introduction
Neural systems communicate through coordinated synaptic neurotransmitter re-
lease and electrophysiological signals, yet few tools exist for simultaneously recording
these multimodal neural signals with high spatial and temporal resolution. Bridging
the electrophysiological and neurochemical domains with sufficient fidelity, resolu-
tion, sensitivity, and selectivity can provide novel insights into neurophysiology that
lead to improved therapeutic approaches for treating neurological disorders (Villa
et al., 2000; Hammond et al., 2007; Agid et al., 2007; Kipke et al., 2008; Johnson
et al., 2008; Rohatgi et al., 2009; Howe et al., 2010; Frey et al., 2010; Agnesi et al.,
2010). For example, real-time monitoring of multimodal neural activity during drug
delivery may have significant implications for improving drug development processes,
disease diagnosis, and therapy (Agid et al., 2007; Rohatgi et al., 2009; Seidl et al.,
2010). Combining electrophysiology, biosensing, and drug delivery capabilities has
the potential to greatly expand investigations of neural systems.
Microelectrodes are commonly used for high-density recording of electrophysio-
26
logical activity from individual neurons and neuronal ensembles (Vetter et al., 2004;
Chapin, 2004; Patil et al., 2004; Moxon et al., 2004; Buzski, 2004; Zhang et al., 2009;
Ludwig et al., 2011). Additionally, in vivo voltammetry with carbon and platinum
microelectrodes is an established method for electrochemically sensing various neuro-
chemicals including dopamine, serotonin, acetylcholine, choline, and glutamate with
sub-micromolar (µM) sensitivity and sub-second temporal resolution (Garguilo and
Michael, 1995; Burmeister et al., 2002, 2003; Mitchell, 2004; Parikh et al., 2007; Has-
cup et al., 2008; Kile et al., 2010; Zachek et al., 2010; Flagel et al., 2011). In some
cases, these modalities have been combined by alternating between electrophysiology
and neurochemical recordings at a single electrode (Cheer et al., 2005) or by extract-
ing low frequency local field potentials from amperometric neurochemical recordings
(Zhang et al., 2009).
In vivo voltammetry utilizes a potentiostat to apply a voltage waveform at a mi-
croelectrode implanted in the brain to produce a current from the oxidation and/or
reduction of analytes at the electrode surface (O’Neill, 1994; Robinson et al., 2008).
The resulting faradaic current is proportional to the analyte concentration within
the sensor’s linear range. Some neurochemicals, such as dopamine and serotonin, are
electroactive molecules that undergo oxidation or reduction directly at the electrode
surface. Non-electroactive neurotransmitters, such as acetylcholine and glutamate,
cannot be measured directly with voltammetric methods. The most common ap-
proach for electrochemically detecting these molecules is to enzymatically convert
them to an electroactive reporter molecule (e.g. Hydrogen Peroxide or H2O2) with
an appropriate oxidase enzyme (choline oxidase, glutamate oxidase, etc.) immobi-
lized on the surface of the electrode (Burmeister and Gerhardt, 2001; Mitchell, 2004;
O’Neill et al., 2008; Frey et al., 2010). The H2O2 is then oxidized at the electrode,
which has a typical bias of +0.7V versus Ag/AgCl. With constant potential amper-
ometry, the electrode bias is fixed, and thus the temporal resolution is limited only
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by diffusion and the sampling rate of the potentiostat. In the case of acetylcholine,
endogenous acetylcholinesterase rapidly converts free acetylcholine to choline. Immo-
bilized choline oxidase at the electrode surface catalyzes the reaction of choline to
H2O2, which is measured by its faradaic oxidation current, as described below:
ACh + H2O
AChE−−−→ Ch + Acetic Acid (2.1)
Ch + O2
ChOx−−−→ 2H2O2 + Betaine Aldehyde (2.2)
H2O2 −−−→
+0.7V
O2 + 2H
+ + 2e− (2.3)
Microelectrode arrays provide an excellent platform for multimodal neural probes
because the electrodes can be spaced closely together for high spatial resolution with
dimensions that approach those of the neurons (Buzski, 2004; Johnson et al., 2008;
Seymour et al., 2011). In this work, we present a multimodal probe that enables
concurrent detection of choline, recording of electrophysiology, and localized drug de-
livery. We utilized an electrochemically–aided adsorption protocol (Johnson, 1991;
Strike et al., 1995; Frey et al., 2010) modified for extremely small microelectrode sizes
(area = 625µm2) to selectively functionalize individual sites with immobilized choline
oxidase and a permselective membrane for choline recording, while allowing neigh-
boring sites to remain unmodified for electrophysiology recordings. We validated the
multimodal neural biosensor arrays in anesthetized rat cortex by using the integrated
fluidic channel for precise, localized drug delivery. These results confirm the in vivo
function of the high-density sensing array and highlight the potential for continued
in vivo investigations of neural systems and diseases.
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Figure 2.1: Microelectrode Arrays (A) Schematic of biosensors array with dimensions.
Each sites is independently addressable, and can be used for either choline through
enzyme modification or electrophysiological recordings. The site numbering is used
in subsequent figures. (B) Diagram of electrode clusters with dimensions. The sizes
and spaces are the same for each cluster. (C) Image of an electrode with enzyme
coatings on sites 2,3,5,6, 8, and 9.
2.2 Materials and methods
2.2.1 Fabrication of microsensors
This work utilized custom designed polyimide substrate microelectrode arrays
with 10 independently addressable platinum electrode sites (Neuronexus Technologies,
Inc., Ann Arbor, MI). The electrode configuration comprised three clusters of three
sites placed at the tip, 300µm from the tip and 800µm from the tip with one additional
site placed 5mm from the probe tip (see Figure 2.1). Each site was 25µm × 25µm
(area = 625µm2).
The microelectrode arrays were fabricated on silicon wafers, which served as car-
riers for the microprocessing steps. Silicon oxide (SiO2) was deposited on the wafer
as a sacrificial layer. A base polyimde layer was deposited, followed by platinum de-
position. The platinum was patterned to form the sites, leads, and bond pads. A top
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layer of polyimide was deposited and patterned to define the device shape and expose
the electrode sites and bond pads. This process produced sites slightly recessed (2µm)
from the surface. The arrays were released from the wafer by dissolving the sacrificial
oxide layer. After device release, the arrays were epoxied to a fused silica capillary
(outer diameter = 165µm, inner diameter = 100µm), which served as an integrated
microinjection port for in vivo injections of nanoliter fluid volumes. The arrays were
bonded to a printed circuit board connector that enabled the independent interfacing
of individual microelectrode sites with external instrumentation.
2.2.2 Chemicals
Choline oxidase (ChOx) (EC 1.1.3.17) from arthrobacter globiformis, bovine serum
albumin (BSA), glutaraldehyde, m-phenylenediamine, hydrogen peroxide (H2O2),
choline, ascorbic acid (AA), dopamine (DA), potassium, calcium chloride, sodium
chloride, and neostigmine were purchased from Sigma-Aldrich (St. Louis, MO). A
10X concentrate of phosphate buffered saline (PBS) was obtained from Fisher Scien-
tific (Pittsburgh, PA) and used to make 0.01M PBS. All chemicals were prepared in
ultra pure filtered water (Millipore, Billerica, MA).
2.2.3 Preparation of biosensor arrays
Initial functionality of each site on an array was confirmed through a two-step
process. First, a 1 kHz impedance measurement was conducted using an electro-
chemical potentiostat/galvanostat (Autolab PGSTAT12, Eco Chemie, Utrecht, The
Netherlands). The impedance measurement provides verification that the site has
conductivity and serves as one measure of the site’s ability to record electrophysio-
logical activity (Humphrey and Schmidt, 1990; Kovacs, 1994; Ludwig et al., 2011).
Second, the biosensor arrays were calibrated to H2O2. The electrode sites were im-
mersed in a stirred solution of 0.01M PBS at 37◦C. Electrode sites were biased with
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a constant potential of +0.7V versus an Ag/AgCl reference electrode (Bioanalytical
Systems, Inc., West Lafayette, IN) using multichannel potentiostat systems (BioStat,
Discovery Technology International, LLLP, Sarasota FL) and sampled at 60Hz, the
maximum rate of the potentiostat system. After reaching a stable baseline, H2O2
was added to the solution in two 10µM steps. Only sites that had an H2O2 sen-
sitivity greater than 10pA/µM (1600 pA/µM/mm2) were used for electrochemical
sensing purposes. The sensitivity, limit of detection, and linearity were calculated
using custom automated MATLAB software (The MathWorks, Inc., Natick, MA).
Choline oxidase was immobilized to the electrode surface through electrochemically–
aided adsorption optimized for the electrode sites. Previously published electrochem-
ical enzyme immobilization procedures (Frey et al., 2010; Strike et al., 1995; Johnson,
1991) used electrodes an order of magnitude or more larger than the current micro-
electrode sites (Area = 625µm2). This important difference in size creates functional
differences that affect electrochemical behavior of the electrode. Specifically, as the
electrode becomes smaller, radial diffusion becomes the dominate form of mass trans-
port to the electrode surface, which results in higher edge current densities (see also
Bard and Faulkner, 2001). One effect of increased relative current densities at the
electrode edge can be non-uniform electrodeposition and decreased polymer perfor-
mance. Rothwell et al. (2009) reported that phenylenediamine loses selectivity for
H2O2 over ascorbic acid for electrodes with an edge-to-area ratio exceeding 50cm
−1.
The current electrodes have an edge-to-area ratio of 1600cm−1. Thus, electrochemical
functionalization procedures, while not entirely new, were optimized with the current
technologies to further decrease electrode size and provide increased spatial resolution
within microenvironments of neural systems.
The electrode surface was prepared for deposition with 10 cyclic voltammetry
scans between -0.2V and 1.0V versus Ag/AgCl at 50mV per second in 0.01M PBS.
For choline oxidase deposition, the array was placed in a 100µL solution of 0.075U/µL
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choline oxidase, 1% (w/v) BSA, and 1% (v/v) glutaraldehyde within a custom mi-
crochamber with a stainless steel wire as a counter electrode and Ag/AgCl wire as
a reference. Electrochemically–aided adsorption at the electrode sites proceeded by
a series of 50 current pulses with a magnitude of 31.5nA per electrode site and du-
ration of 5 seconds, followed by a 5-second open circuit relaxation period between
pulses. Multiple electrode sites on a single array were coated simultaneously. The
electrodeposition is represented schematically in Figure 2.2.
(A) No current (B) Pulse (C) Relaxation (D) Deposition
Figure 2.2: Illustration of Electrodeposition Procedure. Electrode sites are selectively
coated with immobilized enzyme, while adjacent sites remain uncoated. Electrode-
poited sites are cycled between current pulses (step b) and relaxation periods (step
c). The pulses attract the charged enzyme to the electrode at a high enough concen-
tration to crosslink with the glutaraldehyde (represented in purple). The relaxation
period (steps c) allows for normal mass transfer and more controlled deposition. The
process results in selective deposition of the enzyme onto specificied sites (site d).
The solution consists of the enzyme (blue), BSA (red), and glutaraldehyde (purple).
A minimum of one site on each array was selected for use as a sentinel or chem-
ical reference site to enable differential measurements for interference rejection and
for verifying choline signals in vivo (Burmeister and Gerhardt, 2001; Parikh et al.,
2004; Frey et al., 2010). The functionalization procedure used a modified solution
composition of 1.5% BSA (w/v) and 1% (v/v) glutaraldehyde, with no enzyme. The
number (50), magnitude (31.5nA/site), and duration (5 sec pulses, 5 sec open) of the
current pulses remained the same. The fluidic channels of the devices were flushed
with ultra-purified water to avoid possible clogging from the solutions following the
enzyme and sentinel coating procedures.
After coating the electrode sites, a bias of -200mV versus Ag/AgCl was applied
in 30 second intervals with a 60 second pause up to 3 times in 0.01M PBS to re-
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Figure 2.3: m-Phenylenediamine Deposition Procedure. The electrode bias was cycled
between 0.0V and 0.7V versus Ag/AgCl at 2mV/sec twice followed by a ramp back
up to 0.7V where the potential was held for 15 minutes.
duce oxides that formed during electrochemically–aided adsorption procedures. All
choline sensing and sentinel sites, but not sites used for electrophysiology, were then
coated with a permselective anti-interference membrane of m-phenylenediamine and
resorcinol to provide selectivity over ascorbic acid, dopamine, and other potential
interferents (Geise et al., 1991; Mitchell, 2004; Burmeister et al., 2008; Frey et al.,
2010). A solution of 5mM m-phenylenediamine and 5mM resorcinol in 0.01M PBS
was mixed and immediately purged of oxygen by bubbling N2 for 30 minutes. Af-
ter placement in the mPD/resorcinol solution, the electrode bias was cycled between
0.0V and 0.7V versus Ag/AgCl at 2mV/sec twice followed by a ramp back up to 0.7V
where the potential was held for 15 minutes.
2.2.4 In vitro calibration
Electrode sites functionalized for choline sensing and referencing were calibrated in
a stirred solution of 0.01M PBS at 37◦C with a constant bias of 0.7V versus Ag/AgCl
(as described above for H2O2 before functionalization). Functionalized sites were
calibrated to ascorbic acid (0-500µM), dopamine (0-10µM), and choline (0-40µM)
in succession within the same solution. The sensitivity, limit of detection, linearity,
and selectivity for choline over ascorbic acid and dopamine were calculated for each
electrode as described previously (Burmeister and Gerhardt, 2001). For selectivity
calculations, if no change was detected or the ratio was greater than 1000:1, a value
of 1000:1 was used for averaging purposes.
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2.2.5 In vivo recordings
All animal procedures were approved by the University of Michigan Committee on
Use and Care of Animals and complied with the NIH guidelines for the care and use of
laboratory animals. Male Sprague-Dawley rats (250-450g, n = 13) were anesthetized
with an intraperitoneal injection of urethane (1500mg/kg) and secured to a stereotaxic
frame. Body temperature was maintained with a heating pad. Craniotomies (2-3mm
in diameter) were made over the prelimbic cortex (AP: +3.0mm, ML: +0.7mm, from
bregma) for implanting the microelectrode array and on the contralateral hemisphere
(AP: 3.0mm, ML: +2.0mm, from bregma) for implanting an Ag/AgCl wire reference
electrode (Paxinos and Watson, 2007). In one group of animals (n = 2), an injection
cannula (Plastics One, Roanoke, VA) was implanted into the right lateral ventricle
(AP: -0.8mm, ML: 1.5mm, DV: -4.3mm) for injection of neostigmine. One bone screw
was placed in each hemisphere for stabilization and grounding for electrophysiology
recordings. The biosensor arrays were connected to a custom multi-channel head-
stage with independently configurable channels that enabled each electrode site to be
accessed by either a potentiostat system for electrochemical recordings or an electro-
physiology recording system. During in vivo recording sessions, the sites designated
for electrochemical recording were biased at 0.7V versus the implanted Ag/AgCl wire
and sampled at 60Hz with a BioStat multichannel potentiostat (Discovery Technology
International, LLLP, Sarasota FL). Sites were allowed to reach a stable baseline for
a minimum of 30 minutes after implantation. Electrophysiology recordings were ob-
tained using a Pentusa neural recording system (Tucker-Davis Technologies, Alachua,
FL). Local field potentials (LFPs) were filtered from 0.1Hz to 100Hz. Probes were
inserted through the craniotomy to target prelimbic cortex (AP: +2.5-350mm, ML:
+0.5-1.5mm; DV: -2.5-3.5; from bregma).
Animals received a series of cortical injections of either choline (10mM), KCl
(70mM KCl, 2.5mM CaCl2, 75mM NaCl), or high KCl (120mM KCl, 2.5mM CaCl2,
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29mM NaCl) through the integrated drug delivery channel. Injections were controlled
using a pressure injection system (Ultra 2415 Workstation, Nordson EFD, East Provi-
dence, RI). Typical injection volumes ranged from 50nL to 500nL and were monitored
by graduated markings on the tubing. Ventricle injections of neostigmine were con-
ducted with a 5µL precision syringe (Hamilton Company, Reno, NV). Neostigmine
was used to verify in vivo that the recordings at choline-sensitive sites represented
choline derived from acetylcholine (Parikh et al., 2004). Neostigmine inhibits the hy-
drolysis of acetylcholine to choline by acetylcholinesterase (see equation 2.1), which
in turn reduces the acetylcholine/choline response at the electrode (see equation 2.3).
After completion of the experiment, probes were removed from the brain and
calibrated to verify functionality; however, only pre-experiment calibrations are used
for sensitivity reporting.
2.3 Results and Discussion
2.3.1 In vitro performance
In this work, we utilized electrodeposition techniques for enzyme immobilization
and polymer deposition to develop microelectrode sites sensitive to and selective for
choline (Table 2.1). Electrodeposition techniques offer the distinct advantage of dis-
crete functionalization of individual electrode sites, while allowing other electrodes
on the same device to remain unmodified, thus it has direct applicability in the de-
velopment of microscale biosensor arrays.
Forms of electrochemically–aided adsorption for enzyme immobilization have been
previously reported using electrodes at least an order of magnitude larger in area than
sites on the current microelectrode arrays (Johnson, 1991; Strike et al., 1995; Frey
et al., 2010). In the present work, we successfully developed electrochemically–aided
enzyme immobilization procedures for choline oxidase deposition on microelectrode
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sites with dimensions of 25µm × 25µm (see Figure 2.1 and Table 2.1).
We successfully polymerized m-phenylenediamine with high selectivity for H2O2
on the microelectrode sites using a combination of slow cycling of the applied bias,
followed by a constant holding potential. The slow cycling eliminates the initial
current surge at the electrode when applying a large bias and results in a stable,
uniform polymer layer. This process was used to minimize detrimental edge effects
during deposition at micreoelectrodes. The final holding potential improves overall
selectivity (Geise et al., 1991; McMahon et al., 2004; Dai et al., 2006; Kirwan et al.,
2007; Rothwell et al., 2009). Previous reports showed that the standard constant
potential technique for phenylenediamine results in poor selectivity for H2O2 over
ascorbic acid on electrodes with edge-to-area ratios exceeding 50cm−1 (Rothwell et al.,
2009). Our modified procedure resulted in high selectivity for electrodes with an edge-
to-area ratio of 1600cm−1 and an area of 625µm2, which is an order of magnitude
smaller than other reported electrodes (Frey et al., 2010; Burmeister et al., 2003).
These procedures, in combination, resulted in differentially functionalized electrode
sites with high levels of performance for choline sensing.
Normalized Limit of AA DA
Sensitivity Sensitivity Detection Linearity Selectivity Selectivity Impedance
pA/µM pA/µM/mm2 µM R2 (Ch:AA) (Ch:DA) MΩ
2.1±0.7 3291±108 0.08±0.09 0.9992±0.0018 896±207 743±432 1.11±0.49
Table 2.1: Probe Performance Specifications for Choline-Electrophysiology Probes
n = 49 for all measurements except impedance where n = 116
Range is ± Standard Deviation
Figure 2.4 shows a typical calibration for three sites modified with ChOx deposi-
tion and one chemical reference site. Table 2.1 summarizes the performance data for
all sensors. The average sensitivity (n = 49) was 2.1 ± 0.7 pA/µM or 3291 ± 108
pA/µM/mm2 with a limit of detection of 0.08 ± 0.09µM and linearity (R2=0.9992 ±
0.0018) across the physiological range (n = 49, reported error is standard deviation).
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Figure 2.4: Choline Sensor Calibration (A) Representative calibration data for a set
of electrode sites on a single biosensor array. Sites 3,6, and 9 were functionalized
with choline oxidase (+ChOx), while site 7 served as a reference site with no choline
oxidase (-ChOx). Arrows show injections to adjust the concentration of ascorbic acid
(AA: 20µM, 100µM, 200µM, 500µM), dopamine (DA: 2µM, 10µM), and choline (Ch:
10µM, 20µM, 30µM, 40µM). (B) The sensitivity plot for choline of the electrode sites.
The biosensors also exhibited high selectivity over ascorbic acid (896:1) and dopamine
(743:1). The sensitivity, when adjusted for area, compares favorably to other ampero-
metric biosensors for choline, which have a reported range of 1200-4000 pA/µM/mm2
(Parikh et al., 2004; Burmeister et al., 2003; Frey et al., 2010). Electrode sites also had
impedance measurements (avg = 1.11MΩ) appropriate for electrophysiology (Table
2.1).
2.3.2 In vivo, concurrent choline and electrophysiology recordings
Biosensor arrays were implanted into the prelimbic cortex and validated through
local injections of choline, KCl (70mM), or high molarity KCl (120mM). Figure 2.5
shows the response of three choline sensitive sites (Sites 9, 6, and 3) and a sentinel
site (Site 1) spatially distributed across the array during a series of 200nL and 400nL
injections of 10mM choline. The sensing sites show responses that are both volume-
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Figure 2.5: Choline–Induced Choline Responses (A) Local injections of choline indi-
cate that the electrodes maintain sensitivity in vivo. The responses are dependent on
both injection volume and proximity to the injection port. (B) The average responses
of each injection volume for site 3 and site 5. Site 3 has better resolution of choline
injection volume than site 5 due to its proximity to the choline injection.
and spatially-dependent, while the sentinel site shows no appreciable response. The
choline responses show a spatial dependence with stronger responses near the delivery
port. Immediately at the injection site, the different volumes are distinguishable by
response magnitude. The reasons for nonlinear in vivo responses may include signal
saturation, reuptake parameters, and/or induced signal cascades (Frey et al., 2010).
At 300µm (Site 5) from the injection port, the injections induce measurable responses
from both the 200nL and 400nL injections, but factors such as reuptake and diffusion,
affect the local concentration such that the volumes become indistinguishable. At
800µm (Site 9), the effects of the choline injections are essentially immeasurable,
although other signal cascades may be, and likely are, induced by such injections.
In addition to validating in vivo sensitivity, these measurements provide a measure
of the spatial ’footprint’ of injections through the delivery port. While this pattern
of spatially dependent responses is not unexpected, it is an important consideration
for localized drug delivery studies. Small changes in the placement of an injection
cannula in relation to a sensor can have significant effects on measured responses due
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to physical (diffusion) and biological (reuptake, signal cascades) effects, even with
highly responsive sensors.
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Figure 2.6: K+–Induced Depolarization Responses (A) Injections of various volumes
of 70mM KCl cause local ACh release, which is recorded at the sensor sites. Response
magnitudes are effected by spatial proximity to the injection site and injection volume.
(B) The average magnitude of the responses at sites 3 and 6 for the data in (A).
Biosensor function was further verified through controlled injections of KCl to
elicit acetylcholine release through depolarization. K+–evoked responses were robust
and repeatable (Figure 2.6). As seen with choline–induced responses, the K+-induced
ACh responses were dependent on spatial relationships and injection volumes. Inter-
estingly, and in contrast to choline injections, the responses of the sites nearest the
injection site frequently have a smaller magnitude than those slightly further away
(see also Figure 2.7). One plausible explanation for this effect is that the injection
dilutes the local chemical concentrations in the immediate vicinity of the injection
port. As it diffuses, the dilution effect is reduced, but the concentration of K+ remains
high enough to cause ACh release through depolarization.
In Figure 2.6, the recording sensor site nearest the drug delivery port (Site 3)
and the one separated by 300µm (Site 6) both show a response to injections of 70mM
KCl. The more distal recording site (800µm from the point of injection) has a distinct
response to KCl injections only at the highest volume (500nL) injections. The site
appears noisy during the injection period, yet pre- and post-implant calibration reflect
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high, stable sensitivity at the site (pre-implant = 2.55pA/µM, baseline = 16pA, post-
implant = 2.38pA/µM, baseline = 17pA). Additionally, baseline data collected before
initial injections were stable (data not shown). These distal cholinergic responses
indicate that this site resided at the edge of the immediate response field of the
injections. The dynamics recorded at this site may reflect slower diffusion of KCl
and/or compensatory feedback mechanisms more distal from the immediate injection
site.
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Figure 2.7: K+-Induced Depolarization Responses with Neostigmine Injections (A)
Injections of 120mM KCl cause local ACh release, but neostigmine reduces that re-
sponse, indicating that the measured response is due to endogenous acetylcholine
release (B) The average magnitude of the responses at sites 3,5,6, and 9 for the data
in (A).
In order to verify that the choline measurements were attributable to endogenously
released acetylcholine, 120mM KCl injections were followed by ventricle injections of
100mM neostigmine to inhibit the hydrolysis of acetylcholine by acetylcholinesterase
(Figure 2.7). The neostigmine attenuated the K+–induced response by 81 ± 14%
(n = 4), which indicates that the recordings are a reflection of acetylcholine release.
This attenuation is similar in magnitude to that seen in validating other choline
biosensors (Parikh et al., 2004; Frey et al., 2010). In the data represented in Figure
2.7, a cholinergic response was recorded even at the most distal site 800µM from the
injection. This may be attributed to the higher KCl concentration (120mM) utilized
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for this experiment, which causes depolarization through a larger diffusion sphere
that included the more distal sites. We most commonly observed responses at the
two sets of sites near the tip, but responses at distal sites varied. While this can be
attributed in part to variations in experimental parameters such as injection volume
or concentration, it may also be affected by differences in probe location, local tissue
damage, reuptake dynamics, neural projections, signal cascades, or other feedback
mechanisms.
The precise, confined deposition of the biosensor coatings allows neighboring sites
to remain unmodified, which is a benefit for multi-modal sensing applications, includ-
ing electrophysiology, where a bare surface is commonly used for recording purposes.
In this work, we were particularly interested in recording local field potentials (LFPs)
as a starting point for combined electrophysiology recordings. LFPs represent the syn-
chronized activity of neural systems, and have been shown to relate to neurochemical
dynamics (Johnson et al., 2008; Zhang et al., 2009). The microelectrode arrays were
able to obtain electrophysiology recordings on a subset of electrode sites, while con-
currently recording cholinergic activity on neighboring sites. Figure 2.8 shows traces
for LFP data (0.1-100Hz) with choline responses during injections of 70mM KCl.
While we were able to record field potentials, we did not typically record unit
activity. The most likely cause of reduced unit activity is the urethane anesthesia,
which has been noted to significantly reduce or eliminate electrophysiology in deep
anesthetic states(Friedberg et al., 1999; Devonshire et al., 2010; Sceniak and Maciver,
2006); however, urethane is commonly used for recording neurochemical responses
in anesthetized animals (Parikh et al., 2004; Burmeister et al., 2003). The ability
to record is a positive sign of the proper function of these electrodes for recording
electrophysiology. Additionally, they have appropriate performance characteristics
to expect unit activity in other experimental setups, which will include behavioral
paradigms in the future.
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Figure 2.8: Simultaneous Electrophysiology, Cholinergic Recording, and Drug Deliv-
ery. Sites 2 and 5 recorded local field potentials, while sites 1 and 3 simultaneously
recorded cholinergic activity
2.4 Conclusion
In this work, we validated a neural biosensor probe that establishes a multimodal
neural interface through choline recordings, electrophysiology recordings, and local-
ized drug delivery. We utilized electrodeposition procedures for choline oxidase im-
mobilization and membrane polymerization to selectively functionalize electrode sites
within a high-density array to provide high spatial and temporal resolution for record-
ing and modulating neural dynamics.
These neural biosensor arrays can provide novel investigation in neurophysiology
and neuropathologies. While the current work focuses on the validation of these
techniques in an acute preparation, future work will investigate the neurochemical
and electrophysiological dynamics within disease models and behavioral experiments.
Furthermore, many other neurotransmitters including, dopamine, serotonin, gluta-
mate, and GABA, play important roles in neurophysiology and neuropathologies and
suggest a strong need for multi-analyte, multimodal neural interfaces. The ability to
record neurochemical and electrophysiology interactions is important for advancing
our understanding of Parkinson’s disease, Alzheimer’s disease, and other neurological
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disorders.
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CHAPTER III
Multi-modal Neural Biosensors for Choline,
Glutamate, and Electrophysiology Recordings with
Localized Drug Delivery
3.1 Introduction
Recent advances in neural microelectrode technologies have greatly expanded in-
vestigations of neural systems from both an electrophysiology perspective (Ward et al.,
2009; Kipke et al., 2008) and neurochemical perspective (Michael and Borland, 2007).
Carbon fiber electrodes are well established for recording dopamine signals, while
amperometric biosensors for monitoring choline/acetylcholine, glutamate, and other
non-electroactive biomolecules have gained increased use (Burmeister and Gerhardt,
2001; Burmeister et al., 2002, 2003, 2005; Michael and Borland, 2007; Parikh et al.,
2004, 2007; Hashemi and Wightman, 2007; Walker et al., 2007; Wassum et al., 2008).
Many electrochemical neural sensors function on a subsecond timescale making them
particularly appropriate for studying fast neurochemical dynamics. Other techniques,
such as microdialysis and radioactive labeling, are unable to monitor these events
(Sarter et al., 2007). This important ability has revealed new information regarding
neurochemical dynamics (Sabeti et al., 2002; Daws et al., 2005; Parikh et al., 2004;
Binns et al., 2005; Bruno et al., 2006; Parikh and Sarter, 2006; Oldenziel et al., 2006),
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and notable differences in the regulation of basal versus phasic dopamine, glutamate,
acetylcholine release (Phillips et al., 2003; Wightman and Robinson, 2002; Day et al.,
2006; Owesson-White et al., 2008; Parikh et al., 2008; Aragona et al., 2009; Agnesi
et al., 2010). These findings may play important roles in the development of disease
therapies.
Virtually all neural function utilizes multiple neurotransmitter systems with com-
plex dynamics at multiple levels. For example, Parikh et al. investigated the roles of
various cortical nicotinic acetylcholine receptor subtypes in the regulation of cholin-
ergic and glutamatergic dynamics in the context of cue detection and attentional
performance (Parikh et al., 2010, 2008). In these studies, the researchers utilized
multiple sets of animals each recording a single neurotransmitter, either choline or
glutamate. While the researchers were effective in these studies, between animal
variations can cloud important aspects of these systems, including comparisons of
concentration levels and precise timing aspects of the involved neurotransmitters and
electrophysiological changes.
This work presents the development and validation of multimodal neural biosensor
arrays for recording and modulating multimodal neural dynamics. We utilize mul-
tiple electrochemical methods for site-selective functionlization coatings of enzymes
(choline oxidase and glutamate oxidase) and polymers (p-3,4-ethylenedioxythiophene
or PEDOT, and poly-m-phenylenediamine) to individual, high-density microelectrode
sites to enable simultaneous recordings of choline, glutamate, and electrophysiology.
The devices also allow for localized drug delivery of precise nanoliter volumes through
an integrated drug delivery channel, which is used for the validation of sensing modal-
ities.
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Figure 3.1: Microelectrode Arrays (A) Schematic of biosensors array with dimensions.
Each sites is independently addressable, and can be used for either choline through
enzyme modification or electrophysiological recordings. The numbering used to iden-
tify the sites is used in subsequent figures. A typical functionalization configuration
for this work was to deposit PEDOT on sites 2 and 5, choline oxidase on sites 3,6,
and 9, glutamate oxidase on sites 1,4 and 7, and neurochemical reference coatings
on sites 8 and 10. (B) Diagram of electrode clusters with dimensions. The sizes and
spaces are the same for each cluster. (C) Image of an electrode
3.2 Materials and methods
3.2.1 Fabrication of microsensors
This work utilized custom designed polyimide substrate microelectrode arrays
with 10 independently addressable platinum electrode sites (Neuronexus Technologies,
Inc., Ann Arbor, MI). The electrode configuration comprised three clusters of three
sites placed at the tip, 300µm from the tip and 800µm from the tip with one additional
site placed 5mm from the probe tip (see Figure 3.1). Each site was 25µm × 25µm
(area = 625µm2).
The microelectrode arrays were fabricated on silicon wafers, which served as car-
riers for the microprocessing steps. Silicon oxide (SiO2) was deposited on the wafer
as a sacrificial layer. A base polyimde layer was deposited, followed by platinum de-
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position. The platinum was patterned to form the sites, leads, and bond pads. A top
layer of polyimide was deposited and patterned to define the device shape and expose
the electrode sites and bond pads. This process produced sites slightly recessed (2µm)
from the surface. The arrays were released from the wafer by dissolving the sacrificial
oxide layer. After device release, the arrays were epoxied to a fused silica capillary
(outer diameter = 165µm, inner diameter = 100µm), which served as an integrated
microinjection port for in vivo injections of nanoliter fluid volumes. The arrays were
bonded to a printed circuit board connector that enabled the independent interfacing
of individual microelectrode sites with external instrumentation.
3.2.2 Chemicals
Choline oxidase (ChOx) (EC 1.1.3.17) from arthrobacter globiformis, bovine serum
albumin (BSA), glutaraldehyde, m-phenylenediamine, hydrogen peroxide (H2O2),
choline, L-Glutamic acid (glutamate), ascorbic acid (AA), dopamine (DA), potassium,
calcium chloride, sodium chloride, 3,4-ethylenedioxythiophene (EDOT), polystyrene
sulfonate (PSS), and nicotine were purchased from Sigma-Aldrich (St. Louis, MO).
L-Glutamate oxidase (EC 1.4.3.11)) was purchased from U.S. Biological (Swampscott,
MA). A 10X concentrate of phosphate buffered saline (PBS) was obtained from Fisher
Scientific (Pittsburgh, PA) and used to make 0.01M PBS. All chemicals were prepared
in ultra pure filtered water (Millipore, Billerica, MA).
3.2.3 Preparation of biosensor arrays
Initial functionality of each site on an array was confirmed through a two-step
process. First, a 1 kHz impedance measurement was conducted using an electro-
chemical potentiostat/galvanostat (Autolab PGSTAT12, Eco Chemie, Utrecht, The
Netherlands). The impedance measurement provides verification that the site has
conductivity and serves as one measure of the site’s ability to record electrophysio-
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logical activity (Humphrey and Schmidt, 1990; Kovacs, 1994; Ludwig et al., 2011).
Second, the biosensor arrays were calibrated to H2O2. The electrode sites were im-
mersed in a stirred solution of 0.01M PBS at 37◦C. Electrode sites were biased with
a constant potential of +0.7V versus an Ag/AgCl reference electrode (Bioanalytical
Systems, Inc., West Lafayette, IN) using multichannel potentiostat systems (BioStat,
Discovery Technology International, LLLP, Sarasota FL) and sampled at 60Hz, the
maximum rate of the potentiostat system. After reaching a stable baseline, H2O2
was added to the solution in two 10µM steps. Only sites that had an H2O2 sen-
sitivity greater than 10pA/µM (1600 pA/µM/mm2) were used for electrochemical
sensing purposes. The sensitivity, limit of detection, and linearity were calculated
using custom automated MATLAB software (The MathWorks, Inc., Natick, MA).
The first functionalization procedure was deposition of PEDOT. PEDOT has been
shown to improve electrophysiology recordings of microelectrodes (Ludwig et al., 2006,
2011; Seymour et al., 2011). Polymerization of PEDOT was conducted in a solution
of 0.01M EDOT and 0.1M PSS in purified water. A constant current of 3nA per
sites applied for 9 minutes for a total charge density of 2.6nC/µm2. Impedance
measurements were taken before and after PEDOT deposition.
Electrode sites were modified for choline and glutamate sensing by immobilization
of choline oxidase and glutamate oxidase, respectively. These enzymes convert choline
and glutamate to H2O2, which can be measured by biasing the electrode to 700mV
versus an Ag/AgCl reference electrode. The oxidation of H2O2 produces a current
proportional to the concentration of the analyte of interest.
Choline oxidase and glutamate oxidase were immobilized to the electrode surface
through electrochemically–aided adsorption optimized for the electrode sites. Previ-
ously published electrochemical enzyme immobilization procedures (Frey et al., 2010;
Strike et al., 1995; Johnson, 1991) used electrodes an order of magnitude or more
larger than the current microelectrode sites (Area = 625µm2). This important differ-
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ence in size creates functional differences that affect electrochemical behavior of the
electrode. Specifically, as the electrode becomes smaller, radial diffusion becomes the
dominate form of mass transport to the electrode surface, which results in higher edge
current densities (see also Bard and Faulkner (2001)). One effect of increased relative
current densities at the electrode edge can be non-uniform electrodeposition and de-
creased polymer performance. Rothwell et al. (2009) reported that phenylenediamine
loses selectivity for H2O2 over ascorbic acid for electrodes with an edge-to-area ratio
exceeding 50cm−1. The current electrodes have an edge-to-area ratio of 1600cm−1.
Thus, electrochemical functionalization procedures, while not entirely new, were op-
timized with the current technologies to further decrease electrode size and provide
increased spatial resolution within microenvironments of neural systems.
The electrode surface was prepared for deposition with 10 cyclic voltammetry
scans between -0.2V and 1.0V versus Ag/AgCl at 50mV per second in 0.01M PBS.
For choline oxidase deposition, the array was placed in a 100µL solution of 0.075U/µL
choline oxidase, 1% (w/v) BSA, and 1% (v/v) glutaraldehyde within a custom micro-
chamber with a stainless steel wire as a counter electrode and Ag/AgCl wire as a
reference. electrochemically–aided adsorption at the electrode sites proceeded by a
series of 50 current pulses with a magnitude of 31.5nA per electrode site and duration
of 5 seconds, followed by a 5-second open circuit relaxation period between pulses.
Multiple electrode sites on a single array were coated simultaneously.
For glutamate oxidase deposition, the array was placed in a 26µL solution of
0.075U/µL glutamate oxidase, 1% (w/v) BSA, and 1% (v/v) glutaraldehyde within a
custom microchamber with a stainless steel wire as a counter electrode and Ag/AgCl
wire as a reference. electrochemically–aided adsorption at the electrode sites pro-
ceeded by a series of 25 voltage pulses with a magnitude of 1.8V vs. Ag/AgCl per
electrode site and duration of 5 seconds, followed by a 5-second open circuit relax-
ation period between pulses. Multiple electrode sites on a single array were coated
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simultaneously. The glutamate oxidase did not deposit effectively to the electrode
site when current pulses were used. Care must be taken during various electrode
deposition procedures to avoid degradation of microelectrode sites.
A minimum of one site on each array was selected for use as a sentinel or chem-
ical reference site to enable differential measurements for interference rejection and
for verifying choline signals in vivo (Burmeister and Gerhardt, 2001; Parikh et al.,
2004; Frey et al., 2010). The functionalization procedure used a modified solution
composition of 1.5% BSA (w/v) and 1% (v/v) glutaraldehyde, with no enzyme. The
number (50), magnitude (31.5nA/site), and duration (5 sec pulses, 5 sec open) of the
current pulses remained the same as for choline oxidase immobilization. The fluidic
channels of the devices were flushed with ultra-purified water after each procdure to
avoid possible clogging from the solutions.
After coating the electrode sites, a bias of -200mV versus Ag/AgCl was applied
in 30 second intervals with a 60 second pause up to 3 times in 0.01M PBS to re-
duce oxides that formed during electrochemically–aided adsorption procedures. All
choline, glutamate, and neurochemical reference sites, but not sites used for electro-
physiology, were then coated with a permselective anti-interference membrane of m-
phenylenediamine and resorcinol to provide selectivity over ascorbic acid, dopamine,
and other potential interferents (Geise et al., 1991; Mitchell, 2004; Burmeister et al.,
2008; Frey et al., 2010). A solution of 5mM m-phenylenediamine and 5mM resorci-
nol in 0.01M PBS was mixed and immediately purged of oxygen by bubbling N2 for
30 minutes. After placement in the mPD/resorcinol solution, the electrode bias was
cycled between 0.0V and 0.7V versus Ag/AgCl at 2mV/sec twice followed by a ramp
back up to 0.7V where the potential was held for 15 minutes.
The typical order of functionalization was: PEDOT polymerization, neurochem-
ical reference coating, choline oxidase immobilzation, glutamate oxidase immobiliza-
tion, m-phenylenediamine polymerization.
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3.2.4 In vitro calibration
Electrode sites functionalized for neurotransmitter sensing and referencing were
calibrated in a stirred solution of 0.01M PBS at 37◦C with a constant bias of 0.7V
versus Ag/AgCl (as described above for H2O2 before functionalization). Functional-
ized sites were calibrated to ascorbic acid (0-500µM), dopamine (0-10µM), glutamate
(0-20µM), and choline (0-40µM) in succession within the same solution. The sen-
sitivity, limit of detection, linearity, and selectivity for glutamate and choline over
ascorbic acid and dopamine were calculated for each electrode as described previ-
ously (Burmeister and Gerhardt, 2001). For selectivity calculations, if no change was
detected or the ratio was greater than 1000:1, a value of 1000:1 was used for averaging
purposes.
3.2.5 In vivo recordings
All animal procedures were approved by the University of Michigan Committee on
Use and Care of Animals and complied with the NIH guidelines for the care and use of
laboratory animals. Male Sprague-Dawley rats (275-450g, n = 7) were anesthetized
with an intraperitoneal injection of urethane (1500mg/kg) and secured to a stereotaxic
frame. Body temperature was maintained with a heating pad. Craniotomies (2-3mm
in diameter) were made over the prelimbic cortex (AP: +3.0mm, ML: +0.7mm, from
bregma) for implanting the microelectrode array and on the contralateral hemisphere
(AP: 3.0mm, ML: +2.0mm, from bregma) for implanting an Ag/AgCl wire reference
electrode (Paxinos and Watson, 2007). One bone screw was placed in each hemisphere
for stabilization and grounding for electrophysiology recordings.
The biosensor arrays were connected to a custom multi-channel headstage with
independently configurable channels that enabled each electrode site to be accessed
by either a potentiostat system for electrochemical recordings or an electrophysiology
recording system. During in vivo recording sessions, the sites designated for elec-
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trochemical recording were biased at 0.7V versus the implanted Ag/AgCl wire and
sampled at 60Hz with a BioStat multichannel potentiostat (Discovery Technology
International, LLLP, Sarasota FL). Sites were allowed to reach a stable baseline for
a minimum of 30 minutes after implantation. Electrophysiology recordings were ob-
tained using a Pentusa neural recording system (Tucker-Davis Technologies, Alachua,
FL). Local field potentials (LFPs) were filtered from 0.1Hz to 100Hz. Probes were
inserted through the craniotomy to target prelimbic cortex (AP: +2.5-350mm, ML:
+0.5-1.5mm; DV: -2.5-3.5; from bregma).
Animals received a series of cortical injections of either choline (10mM), glutamate
(10mM), KCl (70mM KCl, 2.5mM CaCl2, 75mM NaCl), or nicotine (5mM) through
the integrated drug delivery channel. Injections were controlled using a pressure
injection system (Ultra 2415 Workstation, Nordson EFD, East Providence, RI). Typ-
ical injection volumes ranged from 25nL to 500nL and were monitored by graduated
markings on the tubing.
After completion of the experiment, probes were removed from the brain and
calibrated to verify functionality.
3.3 Results
3.3.1 In vitro Performance
We utilized five separate electrodeposition procedures (PEDOT polymerization,
neurochemical reference coating, choline oxidase immobilzation, glutamate oxidase
immobilization, m-phenylenediamine polymerization) to successfully functionalize the
biosensor arrays. Specified sites were independently sensitive to choline or glutamate.
Figure 3.2 demonstrates the calibration of a sensor with two sets of sites modified
separately for choline and glutamate sensings, as well as a chemical reference site.
Table 3.1 and Table 3.2 summarize the performance data of the sensors. The average
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sensitivity of the glutamate sensors (n = 16) was 1.1 ± 0.1 pA/µM or 1763 ± 169
pA/µM/mm2 with a limit of detection of 0.4 ± 0.09µM (reported error is standard
error of the mean). The glutamte biosensors also exhibited high selectivity over
ascorbic acid (822:1) and dopamine (579:1). The corresponding average sensitivity
of the choline sensors (n = 21) was 3.5 ± 0.2 pA/µM or 5617 ± 399 pA/µM/mm2
with a limit of detection of 0.1 ± 0.05µM. The choline biosensors showed similarly
high selectivity over ascorbic acid (855:1) and dopamine (556:1). The high selectivity
on both sensor types is indicative of an effective phenylenediamine polymerization
procedure on the small microelectrode sites (Rothwell et al., 2009).
Table 3.1: Probe Performance Specifications for Glutamate Biosensors
Glutamate Normalized Limit of
Sensitivity Sensitivity Detection Selectivity Selectivity
pA/µM pA/µM/mm2 µM Glut:AA Glut:DA
1.1±0.1 1763±169 0.4±0.09 822±78 579±123
n = 16; Range is ± Standard Error of the Mean
Table 3.2: Probe Performance Specifications for Choline Biosensors
Choline Normalized Limit of
Sensitivity Sensitivity Detection Selectivity Selectivity
pA/µM pA/µM/mm2 µM Ch:AA Ch:DA
3.5±0.2 5617±399 0.1±0.05 855±61 556±105
n = 21; Range is ± Standard Error of the Mean
Notably, the sensitivity of the glutamate biosensors was approximately 30% of the
sensitivity of the choline biosensors; however, reported sensitivity for amperometric
glutamate sensor have frequently shown lower sensitivity than their choline counter-
parts. Typical reported values for glutamate sensors, when normalized area, are in
the range of 900-2200 pA/µM/mm2, while choline sensors have a reported range of
1200-4000 pA/µM/mm2 (Burmeister et al., 2002, 2003; Parikh et al., 2004, 2010; Frey
et al., 2010). Our biosensors have sensitivity that falls within that range.
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(A) (B)
Figure 3.2: Choline-Glutamate Sensor Calibration (A) Representative calibration
data for a set of electrode sites on a single biosensor array. Sites 3 and 6 were
functionalized with choline oxidase (+ChOx), sites 1 and 4 with glutamate oxidase
(+GlutOx), and site 7 served as a neurochemical reference site with no choline en-
zyme (Ref). Arrows show injections to adjust the concentration of ascorbic acid
(AA: 100µM, 200µM, 500µM), dopamine (DA: 2µM, 10µM), glutamate (Glut:10µM,
20µM), and choline (Ch: 10µM, 20µM). (B) The sensitivity plot for choline and
glutamate of the respective biosensor sites.
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Figure 3.3: Impedance of Electrodes Before and After PEDOT. PEDOT coatings
reduced the impedance from an average of 589.1kΩ to 18.8kΩ.
Electrode sites showed impedance measurements appropriate for electrophysiology
both before and after PEDOT coatings. The PEDOT coatings reduced the impedance
from an average of 589.1kΩ to 18.8kΩ, indicating successful polymerization on the
electrode sites (Figure 3.3).
3.3.2 In vivo Validation and Performance
Biosensor arrays were implanted into the prelimbic cortex and validated through
local injections of saline (Ringers), choline, glutamate, KCl, or nicotine. This exper-
imental set is designed primarily to show in vivo function as a foundation for future
neurophysiological investigations.
Saline injections were used as a control to determine the response from pressure
injections. Figure 3.4 shows the data traces for these response. A typical saline
injection evoked a minimal response at normal injection volumes. These responses
were frequently, although not always, reflected in the reference channel as well, which
indicates that the response was due to a transient disruption of the tissue-electrode
interface. On occasions when the reference site did not show similar changes, the
responses were small (≤1–2µM) relative to measurements from KCl, choline, gluta-
mate, or nicotine at similar volumes. The saline injections did not induce changes in
LFP activity.
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Figure 3.4: Saline Injections during recordings of Glutamate, Choline, and Electro-
physiology (A) Glutamate responses are shown in red. Sites 1, 4, and 7 had benchtop
sensitivity responses of 0.8, 0.7, and 1.6pA/µM glutamate, respectively. Choline re-
sponses are shown in blue. Sites 3, 6, and 9 had benchtop sensitivity responses of 2.8,
2.8, and 3.4pA/µM choline, respectively. (B) The average power spectrogram for the
local field potentials also shows no appreciable change. Injection occurred at time 0.
Figure 3.5 shows the response of two choline sensitive sites (Sites 3 and 6 in
blue) and two glutamate sensitive sites (Sites 1 and 4 in red) distributed across the
array during a series of 150nL, 250nL, and 500nL injections of 10mM choline. Local
injections of choline indicate that the choline sites maintain sensitivity in vivo, but
also induce local release of glutamate, which is measured on parallel glutamate sensing
sites. The sensing sites show responses that are volume- and spatially-dependent. In
this particular case, the choline sites, although separated by 300µm, recorded similar
amplitudes. Both had volume dependence distinguishable by response magnitude.
The glutamate responses showed a similar volume dependence, but also had stronger
spatial differences. Interestingly, the sites further from the tip recorded stronger
glutamate responses. We have seen this type of relationship in several experiments,
and it most frequently occurs when the injection agonist is not the analyte being
measured at the electrode site (see also Section 2.3.2 in the previous chapter and the
discussion below).
Glutamate injections also produced regular, repeatable responses at the sensing
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Figure 3.5: Choline–Induced Glutamate and Choline Responses (A) Glutamate re-
sponses are shown in red. Sites 1 and 4 had benchtop sensitivities of 1.5 and
0.8pA/µM glutamate, respectively. Choline responses are shown in blue. Sites 3
and 6 had benchtop sensitivities of 3.9 and 1.7pA/µM choline respectively. (B) The
average glutamate and choline responses (with standard deviation) for each choline
injection volume during the series.
sites as seen in Figure 3.6. Glutamate responses during glutamate injections were
often 10–40X higher than corresponding choline responses at the same depth. Figure
3.6 also demonstrates the concurrent electrophysiology/LFP recordings during these
injections. The responses also show volume and spatial dependence. Site 4, which
is nearer to the injection site than site 7, reflects high concentrations at virtually all
volumes. Site 7 shows a clearer volume dependence, indicative of the greater diffusion
of glutamate concentration further from the injection site.
KCl was injected to elicit cholinergic and glutamatergic responses through direct
depolarization of local neurons (Figure 3.7 and Figure 3.8). KCl–induced responses
were volume dependent for both choline and glutamate. Of particular note, the mag-
nitude of KCl–evoked choline responses were similar in magnitude to the glutamate–
evoked choline responses. Additionally, the magnitude of KCl–evoked glutamate re-
sponses were similar in magnitude to the choline–evoked glutamate responses. In
other words, the KCl caused neurotransmitter release at approximately the same
levels as direct injection of the choline or glutamate.
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Figure 3.6: Glutamate–Induced Glutamate, Choline, and LFP Responses (A) Ex-
ample of a glutamate–induced (10mM, 100nL) response for glutamate (site 4, red),
choline (site 4, blue), LFPs (site 5, black), and chemical reference (site 8, green). (B)
The average response (with standard deviation) of 3 injections. (C) The average peak
heights (with standard deviation) for glutamate and choline sensing sites (n = 3 for
each injection) for the series of injections that includes (A) and (B).
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Figure 3.7: KCl–induced Glutamate and Choline Responses (A) Glutamate responses
are shown in red (sites 1,4). Choline responses are shown in blue (sites 3,6). (B)
The average glutamate and choline responses (with standard deviation) of each KCl
injection volume during the series. (C) The average glutamate response when the
first 100nL injection is removed as a potential outlier.
Local field potentials were also recorded during the KCl injections. As seen in
Figure 3.7, the KCl caused only a brief, transient change in LFPs across the entire
band. As saline did not induce such a change in LFPs, this transient peak reflects
the rapid depolarization during the KCl injection.
As a final evoked response procedure, we injected nicotine, which has previously
been shown to cause both aceteylcholine and glutamate release in the prefrontal
cortex through nAChR-mediated signaling pathways Parikh et al. (2008, 2010). Both
glutamate and choline were recorded at the respective biosensor sites (Figure 3.9).
The electrophysiological response was a large, but brief signal similar to that seen
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Figure 3.8: KCl–induced Glutamate, Choline, and LFP Responses (A) The glutamate
response is shown in red (site 4) and the choline response is shown in blue (site 6). (B)
The average glutamate and choline response for this series of 150nL KCl injections
(with standard deviation). (C) The average power spectrogram for the local field
potentials. Changes occurred directly at injection onset at time 0.
during KCl injections.
3.4 Discussion
In this work, we have presented and validated a multimodal neural probe for
establishing multiple neurochemical, electrophysiological, and pharmacological inter-
faces with the brain. Our results indicate that the sensors have high performance
characteristics (sensitivity, limit of detection, selectivity) that continue to function
well in vivo to enable recordings of glutamate, choline, and electrophysiology in real
time, while also providing an integrated drug delivery interface. As the results from
saline injections and concurrent reference channels indicate, injections with this neural
probe have minimal impact on the measurements; however, care should be taken with
repeated injections or large, rapid injections. Such protocols may result in variability,
tissue damage, and degradation of the electrode-tissue interface.
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Figure 3.9: Nicotine–Induced Glutamate, Choline, and LFP Responses (A) The glu-
tamate response is shown in red (site 4), and the choline response is shown in blue
(site 6). (C) TThe average power spectrogram for the local field potentials. Changes
occurred directly at injection onset at time 0.
An important outcome of this work is the ability to modify closely–spaced mi-
croelectrode sites without affecting other sites on the same array. These procedures
further extended the limits of electrode size and spacing for biosensor arrays. Of
particular note, the modification procedures and coatings were highly compatible,
allowing for multiple different sensing elements with high performance.
Injections of KCl and nicotine resulted in amplitudes at choline sites that were ap-
proximately equivalent to those during glutamate injections. Conversely, glutamate
responses during KCl and nicotine were similar to those seen during choline injections.
This result indicates that the difference in magnitude from KCl– or nicotine–induced
signals compared to the direct neurotransmitter injection can be primarily attributed
to the injected neurotransmitters, and is a positive indicator that our sensors are con-
tinuing to function appropriately. Of additional interest, choline served as an effective
activation agent for causing glutamate release through its role as a nAChR agonist
(Uteshev and Knot, 2005; Gusev and Uteshev, 2010). As Figure 3.5 indicates, during
choline injections, choline induces a glutamate response that is similar in magnitude
to the choline response. In our set of experiments, this was the only condition where
the choline and glutamate responses were similar. Typically, glutamate was much
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higher.
The multisite array also demonstrates interesting aspects of injection or diffusion-
based experiments. In several cases, spatially separated sites reflect similar signal
amplitudes. This may be due to reaching a maximum amplitude, wicking up the
device interface, neural projections that cause similar responses at different depths,
and/or in vivo functional differences due to proximity to vasculature, protein adhe-
sion, and tissue response. Occasionally, sites nearest the injection port show very
low response magnitudes, while more distal sites respond more robustly. We have
seen this type of relationship in several experiments, and it most frequently occurs
when the injection agonist is not the analyte being measured at the electrode site
(e.g. measuring either neurotransmitter during KCl or nicotine injections, measur-
ing choline during a glutamate injection, or measuring glutamate during a choline
injection). While this may seem counterintuitive initially, the injection can produce
a “wash out” effect, or a region immediately around the injection site with lower con-
centration of endogenous analytes due to the injection volume and resulting diffusion.
When injecting the molecule being measured, the most proximal site typically has
at least as robust of a response as the more distal sites (for example, Figure 3.6).
While the current study does not determine an optimal distance for sensor place-
ment in relation to the injection point, this relationship should be considered during
experimental and device design.
In the past, injection-diffusion experiments have been used to study enzyme and
reuptake kinetics (Sabeti et al., 2002; Oldenziel et al., 2006). Clearly, these stud-
ies have provided new insights to neurotransmitter dynamics, but the present results
with spatial differentiation indicate that aspects of these kinetics my be strongly influ-
enced by the infusate bolus and resulting diffusion. For example, KCl injections cause
depolarization by affecting the local concentration of K+. As long as the K+ concen-
tration is locally high even as it diffuses, the membrane potential of local neurons will
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be depolarized and neurotransmitters may be released, unless the supply is exhausted
due to repeated release or high levels of release. Although separate synaptic release
events would not be distinguishable, the period of this concentration threshold could
extend beyond the refractory period, which is on the order of milliseconds. Distance
from the electrode and local tissue differences may play a role in the recorded kinetic
responses, and these factors must be considered during diffusion-based experiments.
Recent work by several groups has focused on understanding characteristics of dif-
fusion in brain tissue, which is complicated by reuptake, receptors, tissue damage,
and device specifications (Gardner-Medwin, 1983; Retterer et al., 2004; Nicholson,
201; Rohatgi et al., 2009). While locally infused molecules may obscure or complicate
aspects of neurophysiology when directly driving a response, such experimental sys-
tems may be very appropriate for delivery of modulators, such as antagonists, when
the physiological response is drive by other means, such as behavioral experiments or
upstream stimulation.
Throughout these experiments, we successfully recorded field potentials, but did
not record unit activity, even with PEDOT coatings. Urethane anesthesia has been
shown to reduce electrophysiology (Friedberg et al., 1999; Devonshire et al., 2010;
Sceniak and Maciver, 2006), as do many anesthetic agents, particularly in deeper
states of anesthesia. The purpose of this set of experiments with regard to electro-
physiology was to 1) validate functionality, which was accomplished through field
potential recordings, and 2) demonstrate compatibility of the various functional coat-
ing procedures, including PEDOT. Both aims were met in the current experiments.
This framework lays the foundation for continued experiments.
3.5 Conclusion
The biosensor arrays presented in this work provide a multimodal neural interface
with the ability to record rapid dynamics of choline, glutamate, and electrophysiology
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combined with local drug delivery. The arrays consist of 10 independent microelec-
trode sites (area = 625 µm2) that enable high-density, spatially distributed recordings.
We utilize multiple electrochemical methods for site-selective functional coatings of
enzymes and polymers to selectively modify multiple electrode sites in various func-
tional configurations on a single electrode array. The in vivo experiments validated
proper function and urge further investigations of neurophysiology and neuropatholo-
gies with this multimodal interface.
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CHAPTER IV
Influence of Calibration Media on Performance
Characteristics of Amperometric Biosensors:
Implications for in vivo Measurements
4.1 Introduction
Electrochemical biosensors are in active use and development for the detection
of many biological analytes, including glucose, acetylcholine, choline, glutamate, lac-
tate, dopamine, and cholesterol (Wilson and Gifford, 2005; Johnson et al., 2008;
Trkarslan et al., 2009; Moatti-Sirat et al., 1992; Aravamudhan et al., 2007; Jena and
Raj, 2011; Ryan et al., 1997; McMahon et al., 2006; Hamdi et al., 2006; Mitchell, 2004;
Burmeister and Gerhardt, 2003; Burmeister et al., 2005, 2003; Zachek et al., 2010a;
Heien et al., 2005; Bowser and Kennedy, 2001; Shou et al., 2004). Frequently, these
biosensors measure the concentration of analytes of interest within a physiological
environment, such as a fluid sample. In many cases, the biosensor may be implanted
directly in tissue for in vivo measurements (Johnson et al., 2008; Burmeister and
Gerhardt, 2003; Burmeister et al., 2005; Heien et al., 2005). The complex environ-
ments of the body pose a significant difficulty for obtaining accurate physiological
measurements due to interactions of biological constituents with the sensor that may
affect its performance.
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Biological sensors are calibrated for sensitivity to the desired analyte and selectiv-
ity over potential interferents. These calibration factors are then used to translate raw
measurements (typically current) to analyte concentration within the desired physi-
ological system. Ideally, the calibration environment is identical or equivalent to the
environment in which recordings will take place (Phillips and Wightman, 2003; Wil-
son and Gifford, 2005; Webster and Clark, 1998; Periasamy et al., 2011; Moatti-Sirat
et al., 1992; Poitout et al., 1993; Abel et al., 1984; Gifford et al., 2005; Updike et al.,
2000; Aravamudhan et al., 2007).
Unfortunately, calibration procedures for developing biosensors often vary across
the field. These differences may influence the characterization of the sensors and, more
importantly, the degree to which the benchtop characterization accurately represents
performance within physiological environments. Finding appropriate calibration me-
dia and developing robust calibration procedures can be difficult. In some cases,
such as for glucose or cholesterol sensors, blood or serum may be used as an in vitro
media to approximate the recording environment (Updike et al., 2000; Aravamud-
han et al., 2007; Poitout et al., 1993). Implantable neural biosensors do not have
a readily accessible media analagous to the brain. Typically a buffered electrolyte
is used as the calibration media. Common media choices vary, but include artificial
cerebrospinal fluid, phophate-buffered saline, and Tris-buffered saline (Mitchell, 2004;
Johnson et al., 2008; Hamdi et al., 2005, 2006; Kume-Kick and Rice, 1998; Burmeister
et al., 2002; Zachek et al., 2010b; Hashemi et al., 2009). Concentration range and
testing of selectivity over potential interferents differ as well.
While appropriate calibration procedures have been encouraged in the literature
(as an example, see Phillips and Wightman, 2003), little work has been done to estab-
lish common standards. One noteworthy example includes a 1998 study conducted
by Kume-Kick and Rice. This studied showed that the presence of divalent cations
Mg2+ and Ca2+, which are both present in brain tissue, could reduce the sensitivity of
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dopamine at carbon fiber electrodes when using fast-scan cyclic voltammetry. Their
results suggested a reduction in the active surface of the carbon due to occupation
of redox sites by Mg2+ and Ca2+. Kume-Kick and Rice appropriately suggested that
the effects of cations should be considered for voltammetric techniques using carbon
electrodes. This recommendation is typically followed and carbon fiber electrodes are
generally calibrated in electrolyte media containing Mg2+ and Ca2+.
The Kume-Kick and Rice study did not include other electrode materials, such
as platinum, which has since been used as the primary metal for various ampero-
metric neural biosensors. Platinum electrodes are particularly common for enzymatic
biosensors that employ H2O2 as a reporter molecule for glutamate, choline, or other
neurochemicals (Burmeister et al., 2003; Mitchell, 2004; Parikh et al., 2004; Wassum
et al., 2008). The following generalized reactions describe these processes (“Ox” rep-
resents an oxidase enzyme and “FAD” represents flavin adenine dinucleotide, which
becomes FADH2 when oxidized) (Rothwell et al., 2009):
Substrate + Ox/FAD→ Products + Ox/FADH2 (4.1)
Ox/FADH2 + O2 → Ox/FAD + H2O2 (4.2)
H2O2 → O2 + 2H+ + 2e− (4.3)
Amperometric biosensors commonly utilize a permselective membrane, such as
Nafion or phenylenediamine, to provide selectivity over potential interferents (Parikh
et al., 2004; Mitchell, 2004; Frey et al., 2010; Kirwan et al., 2007; Burmeister et al.,
2008).
This work investigates the effects of calibration media, analyte concentration
range, and functional coatings on the characterization of platinum electrode am-
perometric biosensors. While amperometric biosensors are widely used for a variety
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sensors, this work focuses on applications in neural biosensors, such as those for
recording choline, glutamate, glucose, and dopamine.
4.2 Materials and methods
4.2.1 Fabrication of microsensors
The microelectrode arrays used in this work were designed for benchtop testing,
and are non-implantable devices. They consisted of six round microelectrodes sites
with diameters of 50µm (area = 1963µm2) or 55µm (area = 2376µm2). Only elec-
trodes of identical dimensions were used within each group or for comparison between
groups.
Arrays were fabricated on silicon wafers using standard planar photolithography
microfabrication techniques with photoresist patterning. The devices consisted of
four layers: silicon substrate, sputtered gold traces for connecting the electrode sites,
sputtered platinum electrode sites, and silicon nitride deposited by plasma-enhanced
chemical vapor deposition. The silicon nitride served as a dielectric insulation layer.
The probes were dice cut and wire bonded to custom printed circuit boards. Each
electrode was independent of other electrode sites and could be accessed individually.
4.2.2 Chemicals
Choline oxidase (ChOx) (EC 1.1.3.17) from arthrobacter globiformis, bovine serum
albumin (BSA), glutaraldehyde, m-phenylenediamine, hydrogen peroxide (H2O2),
choline, ascorbic acid (AA), dopamine (DA), potassium chloride (KCl), sodium chlo-
ride (NaCl), sodium dihydrogen phosphate (NaH2PO4), disodium hydrogen phos-
phate (Na2HPO4), monopotassium phosphate (KH2PO4), sodium bicarbonate (NaHCO3),
glucose, calcium chloride (CaCl2), magnesium chloride (MgCl2) were purchased from
Sigma-Aldrich (St. Louis, MO). All chemicals were prepared in ultra pure filtered
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water (Millipore, Billerica, MA).
We conducted calibrations in four electrolyte solutions: 0.01M phosphate buffered
saline (“0.01M PBS”: 137mM NaCl, 2.7mM KCl, 1.9mM KH2PO4, 10mM Na2HPO4),
0.05M phosphate buffered saline (“0.05M PBS”: 100mM NaCl, 10mM NaH2PO4,
40mM Na2HPO4), artificial cerebrospinal fluid (“aCSF”: 126mM NaCl, 3.5mM KCl,
1.2mM NaH2PO4, 25mM NaHCO3, 2mM glucose, 2mM CaCl2, 1.3mM MgCl2), and
a tris-buffered electrolyte (“TBE” 15mM Tris, 140mM NaCl, 3.25mM KCl, 1.25mM
NaH2PO4, 1.2mM CaCl2, 1.2mM MgCl2, 2 NaSO4). Each calbration media was pH
balanced to 7.3-7.4. The aCSF was bubbled with a gas mixture of 95% O2, 5% CO2
to maintain constant CO2 levels for proper buffering.
4.2.3 Preparation of Sensors
Electrodes were divided into four groups for testing: bare/unmodified, Nafion-
coated, m-phenylenediamine (mPD) coated, or choline oxidase and mPD (ChOx+mPD).
Nafion was deposited by dip-coating, followed by oven drying at 175◦C for 3 minutes
(Burmeister et al., 2002). mPD was deposited by electrodeposition (Geise et al.,
1991; Mitchell, 2004; Burmeister et al., 2008; Frey et al., 2010). A solution of
5mM m-phenylenediamine and 5mM resorcinol in 0.01M PBS was mixed and im-
mediately purged of oxygen by bubbling N2 for 30 minutes. After placement in the
mPD/resorcinol solution, the electrode bias was cycled between 0.0V and 0.7V versus
Ag/AgCl at 2mV/sec twice followed by a ramp back up to 0.7V where the potential
was held for 15 minutes.
Choline sensitive electrodes (ChOx+mPD) were modified by depositing a droplet
of a mixture consisting of 1% choline oxidase, 1% BSA, and 0.125% glutaraldehyde
in water (Burmeister et al., 2003). This mixture was allowed to cure on the electrode
sites for approximately 48 hours. After the curing period, mPD was deposited on the
electrode sites as described above.
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4.2.4 Calibrations
Calibration procedures were conducted by immersing the electrodes in a stirred
solution of an electrolyte solution (0.01M PBS, 0.05M PBS, aCSF, TBE) at 37◦C.
Electrode sites were biased with a constant potential of +0.7V versus an Ag/AgCl ref-
erence electrode (Bioanalytical Systems, Inc., West Lafayette, IN) using multichannel
potentiostat systems (BioStat, Discovery Technology International, LLLP, Sarasota
FL) and sampled at 60Hz, the maximum rate of the potentiostat system. After reach-
ing a stable baseline, the electrodes were calibrated with increasing concentrations of
H2O2, dopamine, ascorbic acid, and/or choline.
H2O2 calibrations were performed from 0-40µM using the following steps: 1µM,
2µM, 3µM, 4µM, 5µM, 10µM, 15µM, 20µM, 30µM, 40µM. H2O2 calibrations were
performed on bare, Nafion, and mPD electrodes. Choline sensitive sites were simi-
larly calibrated with the same concentration steps, but with choline instead of H2O2:
The different calibration step sizes allowed us have increased resolution to determine
whether or not the sensors had any concentration-dependent sensitivity. A subset of
Nafion-coated electrodes was calibrated for dopamine from 0-40µM using 10µM steps.
Amperometric sensing of dopamine has also been reported in the literature and this
measurement also provided more direct connection to the Kume-Kick and Rice (1998)
report (Johnson et al., 2008). Each sensor was calibrated in each buffer 3 times. The
order of calibration was randomized to avoid skewing results from possible changes
in the electrode performance over time.
Sensitivity calculations were calculated with custom automated MATLAB soft-
ware (The MathWorks, Inc., Natick, MA). Repeated measures ANOVA followed by
pairwise t-tests with a Bonferroni correction were conducted in SPSS software (IBM
Corporation, Armonk, NY) to determine statistical significance of sensitivity differ-
ences between the calibration media. For purposes of this study, p–values less than
0.01 were considered significant. A second level of functional significance was also
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defined as p<0.01 and a percent difference greater than 30%. This additional level
of significance was chosen for two reasons. First, electrode sensitivities have some
inherent variability in the calibration results. Second, while in several incidences a
p–value may indicate significance, functionally that difference may have little rele-
vance. The 30% level was chosen as a conservative measure of statistical significance
and functional relevance.
4.3 Results
H2O2 was chosen as a baseline calibration molecule due to its role in the sens-
ing mechanisms of many amperometric biosensors. Figure 4.1 shows the results of
H2O2 calibrations on bare electrodes, Nafion coated electrodes, and mPD coated elec-
trodes in each of the four calibration electrolytes. In general the phosphate-buffered
solutions perform similarly. Likewise, the aCSF and TBE typically perform quite sim-
ilarly. For bare electrodes, the calibration differences are both statistically (p<0.01)
and functionally different (≥30%) between either of the phosphate buffers and each
of the aCSF and TBE solutions. This difference is most pronounced for the bare
electrodes and mPD-coated electrodes, while at the Nafion electrodes the difference
is statistically significant, but less pronounced. The effect may be mitigated by the
overall reduced sensitivity that occured with the Nafion coatings.
In order to determine the cause of the significant differences in calibration per-
formance among the calibration solutions from Figure 4.1, we tested parts of aCSF
to build the entire solution stepwise. We began by testing the electrodes in various
components of the electrolye buffer (BC = buffer components, BC1 = 126mM NaCl,
3.5mM KCl, 1.2mM; BC2 = BC1 + NaH2PO4, 25mM NaHCO3; BC3 = BC2 + 2mM
CaCl2; BC4 = BC2 + 2mM MgCl2)
When calibrated piecewise in this manner, we determined that the decrease in
sensitivity was directly attributed to the presence of Ca2+ or Mg2+ (see Figure 4.2)
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Figure 4.1: H2O2 Calibrations at (A) Bare electrodes (n = 84 in each calibration
solution), (B) Nafion coated electrodes(n = 33), and (C) mPD coated electrodes (n
= 21).
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Figure 4.2: Calibration in Components of aCSF. The various buffer compositions are
described in the text, but most importantly, BC3 contains Ca2+ and BC4 contains
Mg2+ (n = 6).
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Figure 4.3: Nafion Coated Dopamine Calibrations in each of the calibration media (n
= 12).
In addition to H2O2 calibrations, we also performed dopamine calibrations on
a subset of the Nafion coated electrodes (see Figure 4.3). The dopamine sensing
showed a similar response pattern as the H2O2 testing, thus indicating the changes
in the sensitivity are primarily due to the effects at the electrode that interfere with
the oxidation processes, and not due to specifically to the H2O2.
Fully functionalized enzyme-based biosensors generate H2O2 locally, and may have
different diffusion characteristics. Additionally, the measured H2O2 has not circulated
in the builk solution. In order to determine whether the oxidation processes would
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Figure 4.4: Choline sensor calibrations in each of the calibration media (n = 62)
be similarly affected with these differences, we calibrated fully functionalized (choline
oxidase and mPD) choline biosensors. As seen in Figure 4.4, the responses to choline
also showed significant reductions in aCSF and TBE.
By calibrating across a wide range (0-40µM) and using many concentration steps,
were were able to determine the concentration of the sensor at various concentra-
tion points. We were specifically interested in the differences at the lower (0-2µM)
and upper (20-40µM) ranges. Figure 4.5 shows the results for H2O2 at bare elec-
trodes. Differences in the sensitivity at 0-2µM compared to 20-40µM were found in
0.01M PBS, 0.05M PBS, and aCSF. It should be noted that the sensors had very
linear responses (R2 ≥0.98) for the entire range (0-40µM) as well as the upper and
lower components, thus these changes in sensitivity are not entirely obvious, and are
impossible to see with large concentration steps.
We conducted a similar sensitivity-concentration comparision for the fully func-
tionalized choline sensors (Figure 4.6). In this case, differences in the sensitivity at
0-2µM compared to 20-40µM were found in 0.01M PBS, 0.05M PBS, and TBE, but
not in the aCSF.
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Figure 4.5: H2O2 Sensitivity on Bare Electrodes by Concentration and Calibration
Media (n = 84)
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4.4 Discussion and Conclusion
The results presented here demonstrate that various commonly used calibration
media can significantly alter reported sensor performance. This effect is similarly seen
on carbon microelectrodes (Kume-Kick and Rice, 1998). Specifically we determined
that the presence of Mg2+ and Ca2+ reduce sensitivity compared to standard phos-
phate buffered saline solutions. These effects were seen on electrodes modified with
functional coatings of Nafion, mPD, and choline oxidase with mPD. The finding that
these cations similarly affect H2O2, dopamine, and choline-derived H2O2 oxidation
processes indicates that the effect is not molecule dependent. It strongly suggests
that the interaction occurs at the electrode interface, and not in the bulk solution
since choline-derived H2O2 takes place locally at the electrode.
We additionally found sensitivity differences at different parts of the calibration
range related to concentration, with slightly higher sensitivities at lower concentra-
tions. Functionally, these differences may vary by sensor type, and may not affect
the integrity of measurements in all situations; however, these data suggest that cal-
ibrations within the physiological range are more relevant to in vivo measurements
than tests for expansive linearity ranges. For example, it is common practice to test
choline sensors up to 80µM concentrations and above, even when physiological record-
ings show responses in the range of 1-10µM. The differences in sensitivity across a
broad range may be averaged out and appear fairly linear, particularly if large concen-
tration steps are used during calibration, which would adversely affect the accuracy
of measurements.
Electrochemical sensors are commonly used to report absolute concentration levels
of neurotransmitters in vivo (Frey et al., 2010; Parikh et al., 2004; Johnson et al.,
2008; Rutherford et al., 2007; Burmeister et al., 2008). In some cases, they have been
used to determine basal concentration levels (Day et al., 2006) In general, the ability
to record concentration is generally considered a primary advantage of electrochemical
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sensors. These data suggest that the relationship between benchtop calibrations, in
vivo performance, and the conversion of raw data to concentration is not yet well
defined. Clearly, since the neural recording environment contains both Mg2+ and
Ca2+, a model calibration media should include those molecules as well. A decrease in
sensitivity when implanted would, in fact, result in underestimating the concentration
levels; however, it is undetermined to what extent other molecules and proteins in
the extracellular matrix may affect in vivo measurements. In fact, Mg2+ and Ca2+
levels can change due to tissue damage, electrical stimulation, or normal physiological
responses (Jones et al., 1994; Rice et al., 1997; Kume-Kick and Rice, 1998; Torreano
and Cohan, 1997; Berridge, 1998; Lee et al., 2010). Importantly, implantation of a
sensor disrupts the blood brain barrier, which results in albumin diffusing into brain
tissue. Albumin has been shown to directly increase Ca2+ levels in the brain (Nadal
et al., 1995, 1998). This disruption has the effect of further obfuscating physiological
recordings both within a single session if those changes are transient, and between
recording sessions if those changes have significant variability. The magnitude and
time course of those effects must be further verified in vivo, but this work serves as a
foundation point for characterizing their impact on sensor performance.
Although reporting concentrations is desirable and convenient, the present data
suggest that this practice may be inappropriate for various biological sensors. Alter-
natives to reporting concentration may include including the raw data values with
in vitro calibration values, or calculating percent change as is commonly done with
other methods, including microdialysis.
Continued analysis will be required to more closely mimic in vivo conditions during
calibrations to accurately establish the relationship between benchtop characteriza-
tion and physiological measurements.
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CHAPTER V
Conclusion and Future Directions
The primary outcome of this work has been the development and validation of
multimodal neural probes with the ability to record rapid dynamics of choline, glu-
tamate, and electrophysiology combined with local drug delivery.
Chapter II presented the first step in this process: a multimodal probe that en-
ables concurrent detection of choline, recording of electrophysiology, and localized
drug delivery. Key to the success of this work was the development of precise, se-
lective electrodeposition methods for enzyme immobilization and polymerization of
permselective membrane on individual microelectrode sites.
The developments of Chapter III further extended these capabilities to include
glutamate sensing concurrent with choline sensing, electrophysiology recordings, and
drug delivery, thus establishing a multi-analyte interface. As multiple neurotrans-
mitter systems are involved in virtually all neurological functions and disorders, the
ability to simultaneously monitor multiple chemical signals concurrently with electro-
physiology and integrated pharmacological manipulation can serve as a useful tool to
further advances in understanding and treating these disorders.
Finally, the work presented in Chapter IV aims to improve our ability to interpret
in vivo neurochemical recordings by investigating the influence of calibration media
on performance characteristics of amperometric biosensors. We demonstrated that
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differences in calibration procedures can impact reported performance making the
interpretation of both in vitro and in vivo difficult. This work has provided insight to
improve our ability to obtain and interpret physiological neurochemical recordings.
5.1 Suggestions for Future Directions
The multimodal neural sensors presented in this work have potential applications
in a wide range of application areas. Within areas of basic science, many neuro-
logical disorders are not well understood. A multi-dimensional interface may enable
novel investigations into the interactions among neural systems. For example, the
glutamatergic, dopaminergic, and cholinergic systems are all implicated in the patho-
physiology of schizophrenia and other disorders, yet the direct relationships remain
unclear (Sarter et al., 1999; Arco and Mora, 2005). The ability to simultaneously
monitor multiple chemical signals concurrent with unit activity and local field poten-
tials can provide significant insights into neurophysiology, neuropharmacology, and
neuropathology.
One important area of continued development is the validation of these, or similar,
neural probes in behavioral experiments. As discussed in previous chapters, the
purpose of the current experimental set was the validation of these probes. The
fundamental neurophysiology will prove to be even more exciting, with potential for
significant scientific and clinical impact.
One hurdle to this work is developing the ability for long-term sensing. Multi-
modal recording in chronic experiments for extended periods is essentially non-existent.
It is unclear whether the currently developed coatings are sufficiently stable to en-
able long-term recordings, although other single-molecule biosensors with enzyme-
glutaraldehyde-BSA coatings have been used for periods of weeks in the brain (Ruther-
ford et al., 2007; Parikh et al., 2007). Polymer coatings, including forms of phenylene-
diamine, have also been used for longer-term recording (O’Neill et al., 2008). Chronic
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biosensors will require high stability and low noise. Ideally, they will also have a
well-established relationship between sensor performance and recorded responses, as
discussed in Chapter IV.
While the current work has focused on choline and glutamate sensing, many other
potential molecules are of interest for neural recordings. For example, we have re-
cently piloted a multi-analyte sensing system with choline and dopamine. We were
successful in having three independently sensitive electrode sites—choline, dopamine,
and a reference—as illustrated in Figure 5.1. This sensor uses a combination of a
Nafion coating, choline oxidase coating, and phenylenediamine to enable ampero-
metric sensing of choline and dopamine. Other sensing modalities may continue to
increase the power of technology presented here.
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Figure 5.1: Preliminary testing of Choline-Dopamine probe. Site 1 (green) was mod-
ified for selective sensitivity to choline, site 2 (black) for dopamine, and site 3 (red)
for chemical referencing and noise reduction. The arrows indicate infusions of choline
and dopamine.
Multimodal neural biosensors also have potential clinical relevance. For example,
the devices presented in this work were intentially designed to record across multiple
brain regions. This ability may prove useful in providing improved verification of
electrode placement during deep brain stimulation procedures for the treatment of
Parkinson’s disease, essential tremor, and depression.
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5.2 Concluding Remarks
Neural technologies are an exciting and important area of development. Advance-
ments in our ability to interface with the brain offer new hope as they bring us closer
to treatments for neurological disorders. We, as individuals and a society, are directly
impacted by these debilitating diseases. In many ways, diseases of the brain represent
the most frightening and difficult diseases to face. It is my hope that this work may
contribute, even in some small way, to our ability to understand, manage, and more
effectively treat these disorders.
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APPENDIX A
Early Development
There is a story commonly told that when Thomas Edison was asked about his
failed attempts to develop the light bulb, he replied, “I haven’t failed 1000 times. I
found 1000 ways not to invent the light bulb.” Difficult engineering problems fre-
quently require many iterations. The purpose of this appendix is simply to highlight
some of the precursor work in the development process for the neural probes described
in the main body.
A.1 Droplet Methods
Much of the early development work attempted to deposit droplets of the enzyme
solution onto electrodes. The typical enzyme immobilization recipe was similar to
that found in the literature, consisting of 1% choline oxidase, 1% BSA, and 0.125%
glutaraldehyde in water (Burmeister et al., 2003; Mitchell, 2004). Sometimes ascor-
bate oxidase was used in the mixture. Ascorbate oxidase should reduce the potential
interference of ascorbic acid, but phenylenediamine has proven to be sufficient as a
permselective membrane to block ascorbic acid. The typical device used was a non-
implantable silicon “test structure” with electrode sizes similar to future electrode
sizes. This allowed us to show proof of concept. Figure A.1 shows a test structure
and the enzyme droplet over a set of sites.
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Figure A.1: Test Structure and Droplet Immobilization. The top figure shows a
typical test structure design used for early prototyping. The outer circle is a raised
SU-8 edge to create a well around the electrode site. The bottom figure shows a cured
droplet of the immobilized choline oxidase solution
Using the droplet method, we were able to show that the coatings worked to
create functional sensors. The primary limitation of the droplet method is the size
of the droplet. It proved difficult to impossible to selectively coat individual sites or
even groups of sites. One attempt to overcome this was to use a micropipette with a
pressure injection system. In general, the droplets were still too large to coat just one
site or a few sites. The tip of the pipette clogged very readily due to the nature of
the enzyme-BSA-glutaraldehyde solution. Attempts at forming the droplets with the
probes immersed in oil to assist in droplet formation and placement were also met
with limited success.
One set of test devices had wells, designed with the intention of containing the
enzyme solution to one electrode (Figure A.1). While occasionally this was success-
ful, the results were inconsistent and clogging occurred frequently, thus overall this
strategy did not work well. Figure A.2 shows one successful attempt of containing a
fluorescent test solution.
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Figure A.2: Use of Wells for Enzyme Immobilization. The top figure shows the
micropipette at the electrode site injecting a fluorescent test solution. The bottom
figure shows the solution in the well
While coating individual sites with droplets did not seem to be particularly feasible
or reproducible, it was possible to coat one or two sites near the tip separate from
the rest of the electrodes on the tip. This was done by forming a droplet and using
a micromanipulator to slowly immerse only the tip into the solution. After that
step was complete, a second droplet was placed on the electrode much more distally
so that it did not mix with the other coating. One coating was a choline oxidase
immobilization layer, while the other coating was the reference layer (Figure A.3).
This method was tedious and suffered from very low yield. It was successful enough
to coat several probes and pilot in vivo experiments.
The pilot in vivo experiments were conducted by implanting the neural biosensor
probe in the prefrontal cortex and implanting a stimulation electrode in the substantia
innominata. Stimulation resulted in choline release and LFP responses as seen in
Figure A.4 and Figure A.5.
These early attempts were encouraging in terms of the feasibility of microelec-
trode biosensors with adequate performance specifications, but it became clear that
a different technique would necessary to make the processes robust and achieve the
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Figure A.3: Multiple Droplet Coatings. On the left is an uncoated probe. In the
center is a probe coated with mPD. On the right is a probe differentially coated with
a choline oxidase solution and a reference solution
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Figure A.4: Choline-Electrophysiology Recordings During Stimulation. Probes were
implanted in prefrontal-prelimbic cortex. A stimulation probe was implanted into
substantia innominata. Site 1 was used to record cholinergic activity and Site 4 served
as a choline reference. Sites 2 and 3 record electrophysiological activity. Shown here
are the local field potentials (20-90Hz) and unit activity (450Hz-5KHz). Stimulation
(50 biphasic pulses, 100Hz, 2.0ms period, 200A) occurred at time 0. The signal
from site 4 was subtracted from the signal from site 1 to identify the choline-specific
activity.
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Figure A.5: LFP Response to Stimulation. Local field potentials were recorded in
prefrontal-prelimbic cortex before, during, and after stimulation of substantia innom-
inata (50 pluses, 100Hz, 1 ms/phase, 200µA). Stimulation at t = 15 sec. Changes
occurred in Theta (4-7Hz), Alpha (8-12Hz), Beta (12-30Hz) bands immediately after
stimulation.
objective of developing multi-analyte interfaces described in the main text. After
exploring these techniques, searching the literature, and considering the nature of our
electrodes, enzyme, and functional coatings, my focus turned to the development of
electrodeposition techniques.
A.2 Electrodeposition
Two papers in particular served as the starting point for the electrodeposition
techniques: Johnson, 1991; Strike et al., 1995. In the early stages of the development
of electrodeposition techniques, we also used the test structures to show proof of
concept; however, we found that it was best to pursue development on the same
devices we would use. The transition from one style of device to another could affect
the immobilization procedure. In that process we were able to show successful sensor
function on several types of devices. Usha Ramkrishna was particularly helpful in the
first parts of this process.
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One of the first steps was testing current pulses of various magnitude and duration
(Figure A.6). We also looked at different concentrations of the solution, including
some that did not include BSA and were not sensitive, even though a coating was
visible. BSA appears to provide spacing for optimal enzyme function (Figure A.7).
A) B) C)
Figure A.6: Electrodeposition on Test Structures. (A)Probes were placed in a solution
of ChOx (0.34% w/v) and glutaraldehyde (1% v/v). A pulse train of 1 second pulses
followed by 5 seconds open was applied for 7 minutes followed by a second higher
current pulse train of 1 second pulses followed by 5 seconds open was applied for
14 minutes. Current amplitude significantly affected spatial deposition. (B) Probes
were placed in a solution of ChOx (0.34% w/v) and glutaraldehyde (1% v/v). A
pulse train of 1 second pulses followed by 5 seconds open was applied for 30 minutes.
Lower currents over longer times produce even, localized deposition at electrode sites.
(C) Probes were placed in a solution of ChOx (0.5% w/v), BSA (0.5% w/v) and
glutaraldehyde (0.5% v/v). A pulse train of 1 second pulses of 100nA followed by
5 seconds open was applied for 25 minutes. BSA increased deposition and choline
sensitivity.
At one point we began work on using the electrochemically aided immobilization
technique on the ceramic substrate probes and showed good progress. For example,
using a solution of 0.5% w/v Choline Oxidase, 1% w/v BSA, and 1% v/v Glutaralde-
hyde and a pulse train of 30 pulses of 175 nA for 5 seconds per pulse and 5 second
resting phase, we selectively coated a site 15µm by 333µm (area = 4995µm2) to have
choline sensitivity of 12-14pA/µM choline before phenylenediamine deposition (Fig-
ure A.8). Sometimes neighboring sites showed some choline sensitivity, perhaps due
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A) B) C)
Figure A.7: Calibration of Electrodeposited Test Structures. Biosensor probes were
calibrated at increasing chemical concentrations of choline. (A) Calibration of the
probe shown in Figure A.6B. When the enzyme deposition solution did not include
BSA, the sensors performed poorly. (B) Calibration of the probe shown in Figure
A.6C. When BSA was included in the enzyme deposition solution, the sensors per-
formed very well. The BSA is thought to provide spacing for optimal enzyme function.
(C) Sensitivity plot of the probe in (B).
to diffusion or a coating that extended beyond the site to some degree.
Figure A.8: Electrodeposition on a Ceramic Substrate Probe. The coating is confined
to a single site and showed good sensitivity. Site size is 15µm by 333µm.
The electrodeposition techniques proved to be very robust and repeatable with
high sensitivity on a variety of electrode designs. We were able to design probes for
the work in the main text and successfully functionalize multimodal neural biosensor
probes.
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